[go: up one dir, main page]

TWI323260B - Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol - Google Patents

Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol Download PDF

Info

Publication number
TWI323260B
TWI323260B TW91120509A TW91120509A TWI323260B TW I323260 B TWI323260 B TW I323260B TW 91120509 A TW91120509 A TW 91120509A TW 91120509 A TW91120509 A TW 91120509A TW I323260 B TWI323260 B TW I323260B
Authority
TW
Taiwan
Prior art keywords
formula
group
reaction
intellectual property
ministry
Prior art date
Application number
TW91120509A
Other languages
Chinese (zh)
Inventor
Rudolf Romanie Kesteleyn Bart
Louis Nestor Ghislain Dominique
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Priority to TW91120509A priority Critical patent/TWI323260B/en
Application granted granted Critical
Publication of TWI323260B publication Critical patent/TWI323260B/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Description

五、發明說明(1) 本發明係關於製備六氫-吱π南并[2,3_b]n夫喃_3_醇之方法, 以及用於該方法中之新賴中間物。更特定言之,本發明係 關於製備六氫-呋喃并[2,3七]呋喃〇·醇之立體選擇性方法, 及易於接受工業上按比例擴大之方法。 5 六氫-呋喃并[2,3七]呋喃_3·醇為存在於反轉錄酶病毒蛋白 酶抑制劑結構中之一種重要藥理學部份物質,該抑制劑譬 如在fcfhosh 專人,j. Med. Chem. 1996, 39(17),3278-3290,ΕΡ.0 715 618 ’ WO 99/67417及WO 99/658*70中所述者。該刊物均據此 併於本文供參考。 10 製備六氫-吱喃并[2,3七]吱喃_3·醇(式⑺)之數種方法,係V. INSTRUCTION DESCRIPTION OF THE INVENTION (1) The present invention relates to a process for the preparation of hexahydro-indolizranium [2,3_b]n-folly-ol-ol, and a novel intermediate used in the process. More specifically, the present invention relates to a stereoselective method for the preparation of hexahydro-furo[2,3-7]furanol and an easy to accept industrial scale-up method. 5 Hexahydro-furo[2,3-7]furan-3-enol is an important pharmacological moiety present in the structure of the reverse transcriptase protease inhibitor, such as in fcfhosh, j. Med. Chem. 1996, 39(17), 3278-3290, pp. 0 715 618 'WO 99/67417 and WO 99/658*70. This publication is hereby incorporated by reference. 10 Several methods for preparing hexahydro-indolyl [2,3-7]pyran_3·alcohol (formula (7))

HOHO

經濟部智慧財產局員工消費合作社印裝 為已知。Ghosh 等人在 J. Med. Chem· 1996, 39(17), 3278-3290 中 15描述對掌選擇性合成,以獲得(3R,3aS,6aR)與(3S,3aR,6aS)六 氫-吱喃并[2,3七]呋喃-3-醇,呈光學純式,個別自3(R)-蘋果 酸二乙酯與3(S)-蘋果酸二乙酯開始。此方法包括數個步驟 ’譬如稀丙基化步驟,使用鋰二異丙基胺,接著為還原步 驟’及進一步為Swem氧化步驟,接著為臭氧分解之分裂 20 ,及氫硼化步驟,使用9-硼雙環并[3.3.1]壬烷(9-BBN)。Ghosh 等人亦揭示六氫-呋喃并[2,3-]呋喃:醇之(3R,3aS,6aR)與 (3S,3aR,6aS)兩種對掌異構物之外消旋合成,接著為最後產 物之酵素解析。此後述合成係由2,3-二氫呋喃開始,並包 括以N-碘基琥珀醯亞胺與烯丙醇處理該中間物之步驟, 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(2) 接著為在觸媒意即鈷肟存在下之基團環化。臭氧分解之分 裂,接著為還原步驟,提供外消旋六氫·呋喃并[2,3刎呋喃_ 3_醇。光學活性化合物(m^aS^R)六氫·呋喃并[2,3七]呋喃各 醇’係在酵素解析後獲得,接著為矽膠層析。pezeck等人, 5 Tetrahedron Lett.丨986, 27, 37丨5_3718亦描述使用臭氧分解,以 合成六氫-呋喃并[2,3七]呋喃士醇之途徑。六氫_呋喃并[2,3_b] 呋喃-3-醇亦被描述為在光學活性全氫呋喃并—[2,3_,〇]呋喃衍 生物合成上之中間物(Uchiyama等人,Tetrahedr〇n Lett 2〇〇1,42, 4仍3-4656)。在此程序中之關鍵步驟為2,3_二氫呋喃之氧基 10羥硒基化作用。此程序適合在實驗室程度下使用,仍不易 於接^:按比例擴大。雖然由Gh〇sh等人所述之兩種合成途 徑’係以合理產率及高财異構物過量;提供⑽心网 與(3S,3aR,6aS)六氫-呋喃并[2,3七]呋喃_3_醇,但此兩者僅可 適用於實驗室規模,但由於許多原因,並不易於接受工業 15 例擴大。例如’此等已知途徑遭遇到之缺點是利用 經 濟 部 智 慧 財 M. 局 員 工 消 費 合 作 社 印 製 叩貝物料、重金屬及稀有化合物,譬如N_碘基琥珀醯亞 胺、觸媒_、鐘二異丙基胺及9_BBN。必要之臭氧分解 步驟具有之缺點是產生具高度反應性與爆破敏感性之臭氧 化物與過氧化物,使得此步驟太危險,以致不能被應用於 〇業規模再者,臭氧分解以及Swem氣化作用ϋ高度 地放熱,因此,必須在極低溫度下進行。此外消旋途徑需 要在合成之最後步驟中進行酵素解析,接著為石夕膠純化。 又再者,此外消旋途徑遭遇到之缺點是低的整體質量平衡 ’源自以下事實,會導致最後對掌異構上純化合物之解析 -4- 1323260 A7 B7 五、發明說明(3) 步驟,係發生在合成之最後步驟,而其中只有最大50%產 率之所要對掌異構物可被獲得。兩種技藝上已知之途徑, 亦會產生大量廢料,譬如在洗滌操作中之溶劑與鹽。因此 ,此等已知方法不適合在工業規模上用以產生六氫-呋喃 5 并[2,3-b]呋喃-3-醇之光學上純立體異構物。 經濟部智慧財產局員工消費合作社印製 本發明之主要目的係為提供一種製造六氫-呋喃并[2,3-b] -呋喃-3-醇之經改良方法,此係在與此項技藝中已知之方法 及其缺點比較時。另一項目的係為提供一種用以合成六氫 -呋喃并[2,3-b]呋喃-3-醇之方法,其係適於工業上按比例擴 10 大。本發明之另一項目的係為提供一種立體選擇性方法, 包括其中中間物或最後化合物之立體化學係經控制之步驟 ,其允許合成六氫-呋喃并[2,3-b]呋喃-3-醇之立體異構物。 另一項進一步目的係為提供一種方法,其允許以等於或高 於上述方法之總產率,製造六氫-呋喃并[2,3-b]呋喃-3-醇, 15 並具有對掌異構物過量高於50%。本發明之另一項目的係 為提供一種製造六氫-呋喃并[2,3-b]呋喃-3-醇之方法,其係 製自易於取得之起始物質與試劑。本發明之另一項目的係 為提供新穎中間化合物,其可作為六氫-呋喃并[2,3-]呋喃-3-醇合成上之先質使用。 20 本發明作者已驚訝地發現一種新穎且發明之方法,用於 合成六氫-呋喃并[2,3-b]呋喃-3-醇之立體異構混合物或立體 異構物上純式。 因此,本方法係涉及六氫-呋喃并[2,3-b]呋喃-3-醇之合成 ,自式⑴中間物開始,其中P1與P2各獨立表示氫、羥基 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(4) 保護基,或可一起形成毗二醇保護基,使該式⑴中間物 OP2Printed by the Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperatives is known. Ghosh et al., J. Med. Chem. 1996, 39(17), 3278-3290, 15 describe the selective synthesis of palms to obtain (3R, 3aS, 6aR) and (3S, 3aR, 6aS) hexahydro-quinones. Methyl [2,3-7]furan-3-ol, optically pure, starts with 3(R)-diethyl malate and 3(S)-diethyl malate. The method comprises a number of steps 'such as a dilute propylation step using lithium diisopropylamine followed by a reduction step' and further a Swem oxidation step followed by an ozonolysis split 20 and a borohydride step, using 9 Boron-bicyclo[3.3.1]decane (9-BBN). Ghosh et al. also revealed racemic synthesis of hexahydro-furo[2,3-]furan:ol (3R,3aS,6aR) and (3S,3aR,6aS) two palmar isomers, followed by The final product is analyzed by enzyme. The synthesis described hereinafter starts with 2,3-dihydrofuran and includes the step of treating the intermediate with N-iodosuccinimide and allyl alcohol. This paper scale applies to the Chinese National Standard (CNS) A4 specification (210x297). PCT 1323260 A7 B7 V. INSTRUCTIONS (2) This is followed by cyclization of the group in the presence of a catalyst, namely cobalt ruthenium. The ozonolysis is split, followed by the reduction step to provide racemic hexahydrofuran [2,3 hydrazol-3-ol. The optically active compound (m^aS^R) hexahydrofuran [2,3-7]furanol was obtained after enzyme analysis, followed by silica gel chromatography. Pezeck et al, 5 Tetrahedron Lett. 丨 986, 27, 37 丨 5_3718 also describe the use of ozonolysis to synthesize hexahydro-furo[2,3-7]furanol. Hexahydro-furo[2,3_b]furan-3-ol is also described as an intermediate in the synthesis of optically active perhydrofuran-[2,3_,fluorene]furan derivatives (Uchiyama et al., Tetrahedr〇n Lett 2〇〇1,42, 4 still 3-4656). The key step in this procedure is the 10 hydroxy selenylation of the 2,3-dihydrofuran oxy group. This procedure is suitable for use at the laboratory level and is still not easy to connect with: scale up. Although the two synthetic pathways described by Gh〇sh et al. are based on reasonable yields and high yields of excess isomers; provide (10) heart nets with (3S, 3aR, 6aS) hexahydro-furan [2, 3 seven Furan_3_alcohol, but the two are only applicable to the laboratory scale, but for many reasons, it is not easy to accept 15 cases of industrial expansion. For example, 'the shortcomings encountered by these known routes are the use of the Ministry of Economic Affairs, Smart Assets M. Bureau of Staff and Consumers Cooperatives to print mussel materials, heavy metals and rare compounds such as N_iodosuccinimide, catalyst _, Zhong Er Isopropylamine and 9_BBN. The necessary ozonolysis step has the disadvantage of producing highly reactive and explosive odorous ozonides and peroxides, making this step too dangerous to be used in industrial scales, ozonolysis and Swem gasification. ϋ is highly exothermic and must therefore be carried out at very low temperatures. In addition, the racemic pathway requires enzyme analysis in the final step of the synthesis, followed by purification of the Shiqi gum. Furthermore, the disadvantage of the racemization pathway is that the low overall mass balance is derived from the fact that it will lead to the resolution of the final pure compound in the palm of the hand-4- 1323260 A7 B7 V. Description of the invention (3) , occurs in the final step of the synthesis, and only the largest equivalent of 50% yield of the desired palm isomer can be obtained. Two techniques known in the art also produce large amounts of waste, such as solvents and salts in washing operations. Thus, such known methods are not suitable for use on an industrial scale to produce optically pure stereoisomers of hexahydro-furan 5 and [2,3-b]furan-3-ol. The main objective of the present invention is to provide an improved method for producing hexahydro-furo[2,3-b]-furan-3-ol, which is related to the art. The methods known in the comparison and their disadvantages are compared. Another item is to provide a process for the synthesis of hexahydro-furo[2,3-b]furan-3-ol which is suitable for industrial scale-up. Another object of the present invention is to provide a stereoselective method comprising the step of controlling the stereochemistry of an intermediate or final compound which permits the synthesis of hexahydro-furo[2,3-b]furan-3 a stereoisomer of an alcohol. A further further object is to provide a process which permits the manufacture of hexahydro-furo[2,3-b]furan-3-ol, 15 in a total yield equal to or higher than the above process, and having a palm The structural excess is above 50%. Another object of the present invention is to provide a process for the manufacture of hexahydro-furo[2,3-b]furan-3-ol from readily available starting materials and reagents. Another item of the present invention provides a novel intermediate compound which can be used as a precursor to the synthesis of hexahydro-furo[2,3-]furan-3-ol. The authors of the present invention have surprisingly discovered a novel and inventive method for the synthesis of stereoisomeric mixtures or stereoisomers of hexahydro-furo[2,3-b]furan-3-ol. Therefore, the method relates to the synthesis of hexahydro-furo[2,3-b]furan-3-ol, starting from the intermediate of formula (1), wherein each of P1 and P2 independently represents hydrogen and hydroxy. (CNS) A4 size (210 X 297 mm) 1323260 A7 B7 V. Description of invention (4) Protective groups, or together with a diol protecting group, such that the intermediate (OP) of the formula (1)

P1。、人 /H 轉變成式⑶硝基曱烷衍生物,其中R1表示烷基、芳基或 芳烷基,R2表示氫或C(=0)0R3,R3表示烷基、芳基或芳烷 基,或R3,若存在時,與R1,和彼等所連接之原子一起 採用,可形成6至8-員環狀基團,其可視情況被烷基、芳 烷基或芳基取代, OP2 R2 P10.P1. , human / H is converted to a formula (3) nitrodecane derivative, wherein R1 represents an alkyl group, an aryl group or an aralkyl group, R2 represents hydrogen or C(=0)0R3, and R3 represents an alkyl group, an aryl group or an aralkyl group. , or R3, if present, together with R1, and the atoms to which they are attached, may form a 6 to 8-membered cyclic group, which may be optionally substituted with an alkyl, aralkyl or aryl group, OP2 R2 P10.

'COOR1 3 ~N〇2 — 接著,使該硝基曱烷衍生物轉變成式(6)四氫呋喃衍生物 ,其中OR4表示醇化物,譬如烧氧基,例如藉由利用Nef 15 反應,'COOR1 3 ~N〇2 - Next, the nitrodecane derivative is converted into a tetrahydrofuran derivative of the formula (6), wherein OR4 represents an alcoholate such as an alkoxy group, for example, by using a Nef 15 reaction,

HOHO

OH OR4 經濟部智慧財產局員工消費合作社印製 20 然後藉由分子内環化反應,使式⑹中間物轉變成⑺六 氫-呋喃并[2,3-b]呋喃-3-醇。OH OR4 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed 20 The intermediate of formula (6) is then converted to (7) hexahydro-furo[2,3-b]furan-3-ol by intramolecular cyclization.

HO ip -6 本纸張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(s) 上述方法具有之另一項優點是使用易於取得之起始物質 ,譬如經〇-保護之丙二羥醛。其他被使用於該方法中之試 劑,係為安全且可大量取得。再者,該方法之各步驟係以 良好產率,提供所要之化合物。再者,當於適當情況下使 5 用光學上純起始物質與試劑時,該方法之各步驟可以立體 選擇性進行,這允許合成該化合物之純立體異構物形式。 因此,根據本發明之方法易於接受工業上按比例擴大。 在一較佳具體實施例中,本發明係關於用以合成式⑺ 六氫-呋喃并[2,3-b]呋喃-3-醇之方法,其包括以下步驟: 10 a)使式(1)中間物縮合 OP2 造成式(2) α,/5-不飽和酯,其中Ρ1、Ρ2、R1及R2均如上 15 文定義, 〇p2 R2 pi〇^A^Y〇r1 2 0 經濟部智慧財產局員工消費合作社印製 b) 使該式(2)酯與硝基曱烷反應,而造成式(3)中間物, 20 〇P2 R2HO ip -6 This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1323260 A7 B7 V. Description of invention (s) Another advantage of the above method is the use of readily available starting materials. For example, 〇-protected propylene glycol aldehyde. Other reagents used in this method are safe and available in large quantities. Again, the various steps of the process provide the desired compound in good yield. Further, when optically pure starting materials and reagents are used where appropriate, the various steps of the process can be carried out stereoselectively, which allows the synthesis of the pure stereoisomeric forms of the compound. Therefore, the method according to the present invention is easily accepted to be industrially scaled up. In a preferred embodiment, the invention relates to a process for the synthesis of a hexahydro-furo[2,3-b]furan-3-ol of the formula (7) which comprises the steps of: 10 a) making the formula (1) The intermediate condensation OP2 results in the formula (2) α,/5-unsaturated ester, wherein Ρ1, Ρ2, R1 and R2 are as defined above, 〇p2 R2 pi〇^A^Y〇r1 2 0 Ministry of Economics Intellectual Property Printed by the Bureau of Staff Consumer Cooperatives b) reacting the ester of formula (2) with nitrodecane to form intermediate of formula (3), 20 〇 P2 R2

COOFP h c) 使該式(3)中間物接受Nef反應,導致式(4)與(4’)中間物 本紙張尺度適用中國國家標準規格(210 x 297公釐) 1323260 A7 B7 五、發明說明(6)COOFP hc) The intermediate of the formula (3) is subjected to the Nef reaction, resulting in the intermediates of the formulas (4) and (4'). The paper size is applicable to the Chinese national standard (210 x 297 mm). 1323260 A7 B7 V. Description of the invention ( 6)

OR4OR4

d)使該式(4)與(4》中間物轉變成式⑹中間物,及 15d) converting the intermediates of formula (4) and (4) into intermediates of formula (6), and 15

HOHO

OR4 e)藉由分子内環化反應,使式⑹中間物轉化成式⑺化合 物。 在一項更佳具體實施例中,本發明係關於一種用以合成 式(7)六氫-呋喃并[2,3-b]呋喃-3-醇之方法/其包括以下步驟: a)使式⑴中間物與式CHR2 R5 -(:(=0)-0111之適當氧基羰基 亞曱基試劑縮合,其中R1與R2係如上文定義,且R5表 示氫、羧酸酯、鎮鹽或膦酸酯, OP2P1〇_y . 經濟部智慧財產局員工消費合作社印製 造成式(2) ^,石-不飽和酯,其中P1 文定義, P2、R1及R2均如上OR4 e) The intermediate of formula (6) is converted to the compound of formula (7) by intramolecular cyclization. In a more preferred embodiment, the invention relates to a process for the synthesis of hexahydro-furo[2,3-b]furan-3-ol of formula (7) / which comprises the steps of: a) The intermediate of formula (1) is condensed with a suitable oxycarbonylhydrazinyl reagent of the formula CHR2 R5 -(:(=0)-0111, wherein R1 and R2 are as defined above, and R5 represents hydrogen, a carboxylic acid ester, a sulphate or a phosphine Acidate, OP2P1〇_y. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed on the formula (2) ^, stone-unsaturated ester, of which P1 is defined, P2, R1 and R2 are as above

b)使該式(2)酯與硝基甲烷反應,而造成式(3)中間物 本紙張尺度適用中國國家標準規格(210x297公釐) 1323260 A7 B7 五、發明說明(7) OP2 R2 P1〇.b) reacting the ester of formula (2) with nitromethane, resulting in the intermediate of the formula (3). The paper size is applicable to the Chinese national standard (210x297 mm). 1323260 A7 B7 5. Invention description (7) OP2 R2 P1〇 .

c)使該式(3)中間物接受Nef反應,其方式是將其以鹼, 及接著以強酸處理,而造成式(4)與(4,)中間物之混合物 ,其中R4係如上文定義, ... -** __c) subjecting the intermediate of formula (3) to a Nef reaction by treating it with a base, and then with a strong acid, resulting in a mixture of intermediates of formula (4) and (4,), wherein R4 is as defined above , ... -** __

OR4 d)惟若R2不為氫,則使式(4)與(4’)中間物脫羧基化,因 此個別形成式(5)與(5’)中間物,OR4 d) However, if R2 is not hydrogen, the intermediates of formula (4) and (4') are decarboxylated, and thus intermediates of formula (5) and (5') are formed individually.

15 經濟部智慧財產局員工消費合作社印製 e)以適當還原劑,使式(4)與(4’)中間物,其中R2為氫 或使式(5)與(5’)中間物還原,而造成式⑹中間物,及15 Printed by the Intellectual Property Office of the Ministry of Economic Affairs, Employees' Consumer Cooperatives, e) using intermediates of formula (4) and (4') with appropriate reducing agents, wherein R2 is hydrogen or intermediates of formula (5) and (5') are reduced, And cause the intermediate of formula (6), and

f)藉由分子内環化反應,使式⑹中間物轉化成式⑺化合 本纸張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐) 1323260 A7 B7 五、發明說明(8) 物0 在該方法中,於上文所提及步驟之順序,可與上文引述 之字母順序不同。例如,該方法之步驟⑻與⑼可以顛倒 ,其條件是使用式CHR2R8-(=0)-0111之氧基羰基亞曱基試 5 劑,代替式CHR2 R5 -CpCO-OR1之一,而其中R8與R5不同之 處,在於R8不能夠形成Wittig或Homer-Emmons試劑,譬如 鎮鹽或膦酸酯一。〜而且-,若R2為氫,則類似步驟e)中所述者 之CPCO-OR1部份基團之還原,可在步驟(c)Nef反應之前進 行。 10 式CHI^RS-Ceco-OR1之氧基羰基亞甲基試劑,其中R5表 示羧酸酯,係為例如式R1 0-C(=0)-CHR2 ¢:(=0)-0111之二羧酯 。式chWf^-cookjr1之氧基羰基亞甲基試劑,其中R5表 示鎮鹽,可例如具有式(R6 ,其中R6為 烷基、芳基或芳烷基。式CHI^RS-CbCO-OR1之氧基羰基亞 15 曱基試劑,其中R5表示(R70)2P(=0)-,可例如具有式 (R7 0)2 P(=0)-CHR2 -(:(=0)-0111,其中 R7 為烷基、芳基或芳烷 基。 經濟部智慧財產局員工消費合作社印製 適當地,本發明係關於一種方法,其中P1與P2 —起形成 毗二醇保護基,且特別是該毗二醇保護基為酸不安定性保 20 護基,其在Nef反應之鹼處理步驟期間,仍然保受影 嚮。較佳情況是,該毗二醇保護基係選自包括亞曱基、二 苯亞曱基、亞乙基、1-第三-丁基亞乙基、1-苯基亞乙基、 (4-曱氧苯基)亞乙基、2,2,2-三氣亞乙基 '亞異丙基、亞環 戊基、亞環己基、亞環庚基、苯亞甲基、對-曱氧基苯亞 -10- 本纸張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 _ B7 五、發明說明(9) '^ 甲基、,-一甲氧基本亞甲基、34二甲氧基笨亞甲基及 硝基苯亞甲基。在最佳具體實施例中,P1與p2-起形成二 烧基亞甲基’譬如亞異内基或3·亞戊基。 令人感興趣之此二醇保護基係為不會在式⑴'⑺及⑶ 5中間物内造成另一個立體原中心之保護基。 適當地^狀各獨立為Cij基、芳基或芳基&统 基,特別疋(V6烧基,更特別是以與以各獨立為甲基,乙 基、丙基、異丙基、正-丁基、異丁基、第二_ 了基、第三 -丁基及戊基’且較佳各獨立為甲基乙基或第 10 三-丁基。 R1與R3當-起採用而以·r1_r3·表示時,較佳為-cH2或_ CIVCH2·,視情況被Cl,6烧基、芳基或芳基烧基取代。 適當地,^為。—6烷基,特別是R4為曱基、乙基、丙基 、異丙基、正-丁基' 異丁基、第二_ 丁基、第三丁基及 15戊基,且較佳R4為曱基或乙基。 在一較佳具體實施例中,本發明係關於製備六氫呋喃 并[2,3-b]呋喃-3-醇之純立體異構物,特別是(3R 3aS,6aR)六 氫-吱喃并[2>b]吱喃_3_醇之立體選擇性方法。 經濟部智慧財產局員工消费合作社印製 於本文中使用之”羥基保護基,,一詞,係指一種會保護羥 20基以在合成程序期間防止不期望反應之取代基,譬如揭示 於 Greene,有機合成之保護基·’(John Wiley & Sons,New York (1981))中之〇-保護基。〇-保護基包括經取代之曱基醚類, 例如曱氧基曱基、苄氧基曱基、2-甲氧基乙氧基甲基、2-( 三甲基矽烷基)乙氧基甲基、第三·丁基、苄基及三笨甲基 -11 - 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(1〇) ;四氫哌喃基醚類;經取代之乙基醚類,例如2,2,2-三氣 乙基;矽烷基醚類,例如三甲基矽烷基、第三-丁基二甲 基矽烷基及第三-丁基二苯基矽烷基;及經由使羥基與羧 酸反應而製成之酯類,例如醋酸酯、丙酸酯、笨曱酸酯等。 5 於本文中使用之”毗二醇保護基”一詞,係指呈縮醛或縮 酮形式及呈原酸酯形式之保護基。呈縮醛或縮酮基團形式 之保護基,其特殊實例包括亞甲基、二苯亞甲基、亞乙基 、1-第三-丁基亞乙基、1-苯基亞乙基、(4-甲氧苯基)亞乙 基、2,2,2-三氣亞乙基、亞異丙基、亞環戊基、亞環己基 10 、亞環庚基、苯亞曱基、對-甲氧基苯亞甲基、2,4-二曱 氧基苯亞曱基、3,4-二曱氧基苯亞甲基、2-硝基苯亞曱基 等,而呈原酸酯形式之保護基,其特殊實例包括曱氧基亞 曱基、乙氧基亞曱基、二曱氧基亞曱基、1-曱氧基亞乙基 、1-乙氧基亞乙基、1,2-二曱氧基亞乙基、α-曱氧基苯亞 15 曱基、Ν(Ν,Ν-二甲胺基)亞乙基、α-(Ν,Ν-二甲胺基)苯亞曱 基、2-氧亞環戊基等。 經濟部智慧財產局員工消費合作社印製 於本文中使用之”烷基”一詞,單獨或作為基團之一部份 ,係指飽和單價烴基,具有直鏈或分枝狀烴鏈,或於至少 3個碳原子存在之情況中,為環狀烴類或其組合,且含有 20 1至20個碳原子((ν20烷基),適當地為1至10個娘原子 ((:丨·…烷基),較佳為1至8個碳原子(Ci — 8烷基),更佳為1 至6個碳原子(Q-6烷基),而又更佳為1至4個碳原子(Cn 烷基)。烷基之實例包括曱基、乙基、丙基、異丙基、正_ 丁基、異丁基、第二-丁基、第三-丁基、戊基、異戊基、 -12- 本纸張尺度適用中國國家標準(CNS)A4規格(2丨Ox 297公茇) 1323260 A7 B7 五、發明說明(11) 己基、環丙基、環丁基、環戊基、環己基等。於本文中使 用之”芳基”一詞,包括藉由移除一個氫而衍生自芳族烴 之有機基團,及包括單環狀與多環狀基團,譬如苯基、聯 苯基、萘基。於本文中使用之”芳烷基π —詞,係關於式 5 芳基-烧基之基團,其中烧基與芳基均如上文定義。芳烧 基之實例包括苄基、苯乙基等。 〜-於本文中使用之”烷氧基”一詞,單獨或作為基團之一部 份,係指烧基謎基團,其中烧基一詞係如上文定義。貌基 醚基團之實例包括甲氧基、乙氧基、正-丙氧基、異丙氧 10 基、正-丁氧基、異丁氧基、第二-丁氧基、第三-丁氧基 等。 於本文中使用之''立體選擇性方法"與”立體選擇性步驟 "術語,基本上係關於一種方法或步驟,其中當使用光學 上純起始物質時,吾人感興趣化合物之純立體異構物形式 15 ,係在該方法或該步驟結束時獲得。 經濟部智慧財產局員工消費合作社印製 ••立體化學異構物形式”或”立體異構物形式"之術語, 於本文中使用時,係定義所有可能之異構以及構形形式, 由相同原子組成,藉相同鍵結順序結合,但具有不同三次 元結構,其不可交換,這是在該方法期間所獲得之化合物 20 或中間物可具有的。除非另有提及或指出,否則化合物之 化學命名,係涵蓋該化合物可具有之所有可能立體化學異 構形式之混合物。該混合物可含有該化合物基本分子結構 之所有非對映異構物、對掌異構物及/或構形異構物。更 特定言之,立體原中心可具有R-或S-組態,非對映異構物 -13 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(12) 可具有同側-或對側-組態,在二價環狀飽和基園上之取代 基,可具有順式-或反式-組態,且烯基可具有E或厶組態 。該化合物之所有立體化學異構形式,呈純式或呈彼此之 互混物兩者,係意欲被包含在本發明之範圍内。 經 濟 部 智 慧 財 產 局 員 X 消 費 合 作 社 印 5 式⑴中間物及起始物質或試劑之純立體異構物形式, 如本文中所指出者,係被定義為實質上不含該化合物、起 始物質或試劑之相同基本分子結構之其>&對掌-異構物或非 對映異構物形式之異構物。適當地,"立體異構物上純" 化合物 '起始物質或試劑一詞,係關於具有立體異構物過 10 量為至少5〇%(意即最少75%之一種異構物與最高25%之其 他可能異構物),至高達立體異構物過量為100%(意即100 %之一種異構物,而無其他異構物)之化合物、起始物質 或試劑,較佳為具有立體異構物過量為75%,至高達100 %之化合物、起始物質或試劑,更佳為具有立體異構物過 15 量為90%,至高達100%之化合物、起始物質或試劑,又 更佳為具有立體異構物過量為94%至高達1〇〇%之化合物 或中間物,且最佳為具有立體異構物過量為97%至高達100 %。"對掌異構上純,,與,,非對映異構土純”之術語,應以 類似方式瞭解,可是係個別關於討論中之對掌異構物過量 2〇 ,混合物之非對映異構物過量。 一 雖然,製備根據本發明式(7)立體異構物上純化合物之 方法,可有利地採用立體異構上純之起始物質,但一般可 能期望藉由應用技藝上已知之純化程序,進一步純化 化合物與中間物。例如,對掌異構物可藉由其非對映異構 -14- 1323260 A7 B7 五、發明說明(13) 物鹽與光學活性酸之選擇性結晶化作用而互相分離。或者 ,對掌異構物可藉由層析技術,使用對掌固定相分離。 儘管六氫-呋喃并[2,3-b]呋喃-3-醇具有三個立體原中心, 且理論上應出現8種不同立體異構物之事實,但只有4種 立體異構物被視為存在。此係由於雙環狀環結構在六氫-呋喃并[2,3-b]呋喃-3-醇中之剛性所致,這會造成其反式-稠 合之立體異翁物為熱力學上不利的。只有具有順式-稠合 組態之立體異構物才是熱力學上安定的,因此減少六氫-呋喃并[2,3-b]呋喃-3-醇之立體異構物數目,成為下列: 5f) The intermediate of the formula (6) is converted into the formula (7) by the intramolecular cyclization. The paper is applicable to the Chinese National Standard (CNS) A4 specification (210 x 297 mm). 1323260 A7 B7 V. Description of invention (8) Item 0 In this method, the order of the steps mentioned above may be different from the alphabetical order quoted above. For example, steps (8) and (9) of the method may be reversed, provided that an oxycarbonyl hydrazide group of the formula CHR2R8-(=0)-0111 is used, instead of one of the formulas CHR2 R5-CpCO-OR1, wherein R8 The difference from R5 is that R8 is not capable of forming Wittig or Homer-Emmons reagents such as sedative or phosphonate. ~ and -, if R2 is hydrogen, the reduction of the CPCO-OR1 moiety similar to that described in step e) can be carried out prior to the step (c) Nef reaction. An oxycarbonylmethylene reagent of the formula CHI^RS-Ceco-OR1, wherein R5 represents a carboxylic acid ester, for example, a carboxylic acid of the formula R1 0-C(=0)-CHR2 ¢: (=0)-0111 ester. An oxycarbonylmethylene reagent of the formula chWf^-cookjr1, wherein R5 represents a sedative salt, and may, for example, have the formula (R6 wherein R6 is alkyl, aryl or aralkyl. The oxygen of the formula CHI^RS-CbCO-OR1 A carbonylcarbonyl 15 hydrazyl reagent, wherein R5 represents (R70)2P(=0)-, which may, for example, have the formula (R7 0) 2 P(=0)-CHR2 -(:(=0)-0111, wherein R7 is Alkyl, aryl or aralkyl. Printed by the Intellectual Property Office of the Ministry of Economics, Employees' Consumption Cooperative. Appropriately, the present invention relates to a process in which P1 and P2 together form a diol protecting group, and in particular the diol. The protecting group is an acid labyrinth. It is still protected during the alkali treatment step of the Nef reaction. Preferably, the viridane protecting group is selected from the group consisting of an anthracene group and a diphenylarylene. Base, ethylene, 1-tert-butylethylene, 1-phenylethylene, (4-anthoxyphenyl)ethylene, 2,2,2-trisethyleneethylene Isopropyl, cyclopentylene, cyclohexylene, cycloheptylene, benzylidene, p-nonyloxybenz-10- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297) PCT) 1323260 A7 _ B7 Description (9) '^ Methyl, -monomethoxybenzidine, 34 dimethoxy benzylidene and nitrobenzylidene. In the most preferred embodiment, P1 and p2- form Dialkyl imino group such as isoindolyl or 3 pentylene. Interested in this diol protecting group is not to cause another stereogenic center in the intermediates of formula (1) '(7) and (3) 5 The protecting group is suitably a Cij group, an aryl group or an aryl group, and a fluorene group, especially a fluorene group, more particularly a methyl group, an ethyl group, a propyl group, and a different group. Propyl, n-butyl, isobutyl, second yl, tert-butyl and pentyl' and preferably each independently methylethyl or 10th tri-butyl. R1 and R3 when- When it is represented by ·r1_r3·, it is preferably -cH2 or _CIVCH2·, and is optionally substituted by Cl, 6 alkyl, aryl or arylalkyl. Suitably, -6 alkyl, especially R4 is fluorenyl, ethyl, propyl, isopropyl, n-butyl 'isobutyl, second butyl, tert-butyl and 15 pentyl, and preferably R4 is decyl or ethyl In a preferred embodiment, the invention is related to Pure stereoisomer of hexahydrofuro[2,3-b]furan-3-ol, especially (3R 3aS,6aR) hexahydro-indolo[2>b]pyran-3-ol Optional method. The term "hydroxyl protecting group" as used herein by the Intellectual Property Office of the Intellectual Property Office of the Ministry of Economic Affairs, refers to a substituent that protects the hydroxy 20 group to prevent undesired reactions during the synthetic procedure, such as It is disclosed in Greene, the protective group of organic synthesis ('John Wiley & Sons, New York (1981)). The oxime-protecting group includes substituted decyl ethers such as decyloxy fluorenyl, benzyloxyindenyl, 2-methoxyethoxymethyl, 2-(trimethyldecyl)ethoxymethyl Base, tributyl, benzyl and tris-methyl-11 - This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm) 1323260 A7 B7 V. Description of invention (1〇); Tetrahydrogen Piperanyl ethers; substituted ethyl ethers such as 2,2,2-triseoethyl; decyl ethers such as trimethyldecyl, tert-butyldimethylalkyl and Tris-butyldiphenyl fluorenyl; and esters prepared by reacting a hydroxy group with a carboxylic acid, such as acetate, propionate, acetoate, and the like. 5 The term "procarbyl protecting group" as used herein, refers to a protecting group in the form of an acetal or ketal and in the form of an orthoester. A protecting group in the form of an acetal or ketal group, and specific examples thereof include a methylene group, a dibenzylidene group, an ethylene group, a 1-tert-butylethylene group, a 1-phenylethylene group, (4-methoxyphenyl)ethylidene, 2,2,2-triethylene, isopropylidene, cyclopentylene, cyclohexylene 10, cycloheptylene, benzoquinone, pair -methoxybenzylidene, 2,4-dimethoxybenzylidene, 3,4-dimethoxybenzylidene, 2-nitrophenylarylene, etc. Specific examples of the protecting group of the form include an anthracene fluorenylene group, an ethoxylated fluorenylene group, a dimethoxy fluorenylene group, a 1-decyloxyethylene group, a 1-ethoxyethylene group, and 1 , 2-dimethoxyethylidene, α-decyloxyphenylene 15 fluorenyl, fluorene (fluorene, hydrazine-dimethylamino)ethylidene, α-(Ν,Ν-dimethylamino)benzene Amidino, 2-oxocyclopentyl and the like. The term "alkyl" as used herein, as used alone or as part of a group, refers to a saturated monovalent hydrocarbon radical having a straight or branched hydrocarbon chain, or In the case where at least 3 carbon atoms are present, they are cyclic hydrocarbons or a combination thereof, and contain 20 1 to 20 carbon atoms (( ν 20 alkyl group), suitably 1 to 10 maiden atoms ((: 丨·... The alkyl group) is preferably 1 to 8 carbon atoms (Ci-8 alkyl group), more preferably 1 to 6 carbon atoms (Q-6 alkyl group), and still more preferably 1 to 4 carbon atoms ( Cn alkyl). Examples of alkyl include fluorenyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, second-butyl, tert-butyl, pentyl, isopentyl , -12- This paper scale applies to China National Standard (CNS) A4 specification (2丨Ox 297 mm) 1323260 A7 B7 V. Description of invention (11) Hexyl, cyclopropyl, cyclobutyl, cyclopentyl, ring The term "aryl" as used herein, includes an organic radical derived from an aromatic hydrocarbon by the removal of a hydrogen, and includes monocyclic and polycyclic radicals such as phenyl, hydrazine. Alkyl, naphthyl. As used herein, "aralkyl" is a group of the aryl-alkyl group of the formula 5, wherein both an alkyl group and an aryl group are as defined above. Examples of the aryl group include a benzyl group. , phenethyl, etc. - The term "alkoxy" as used herein, alone or as part of a group, refers to a radical, wherein the term "alkyl" is as defined above. Examples of the ether group include a methoxy group, an ethoxy group, a n-propoxy group, an isopropoxy 10 group, a n-butoxy group, an isobutoxy group, a second-butoxy group, and a third-butoxy group. The ''stereoselective method' and 'stereoselective step" terminology used herein is basically a method or step in which a compound of interest is of interest when an optically pure starting material is used. The pure stereoisomer form 15 is obtained at the end of the method or at the end of the step. The Department of Economic Intelligence's Intellectual Property Office employee consumption cooperative prints • • Stereochemical isomer form or “stereoisomer form” , as used herein, defines all possible isomeric and conformational forms, Consists of the same atoms, joined by the same bonding sequence, but with different three-dimensional structures, which are not exchangeable, which may be obtained by the compound 20 or intermediate obtained during the process. Unless otherwise mentioned or indicated The chemical nomenclature of a compound encompasses a mixture of all possible stereochemically isomeric forms of the compound. The mixture may contain all diastereomers, palmomeris and/or conformations of the basic molecular structure of the compound. Isomers. More specifically, the stereogenic center can have an R- or S-configuration, diastereoisomer-13 - this paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1323260 A7 B7 V. INSTRUCTIONS (12) May have an ipsilateral or contralateral configuration, a substituent on a divalent cyclic saturated base, which may have a cis- or trans-configuration, and an alkenyl group It can have an E or 厶 configuration. All stereochemically isomeric forms of the compounds, either in pure form or in intermixing with each other, are intended to be included within the scope of the invention. Intellectual Property Intelligence Officer X Consumer Consortium 5 (1) Intermediate and the pure stereoisomer form of the starting material or reagent, as indicated herein, is defined as being substantially free of the compound, starting material or The same basic molecular structure of the reagents>&isomers in the palmo-isomer or diastereomeric form. Suitably, the term "stereoisomerically pure" compound's starting material or reagent relates to an isomer having a stereoisomer of at least 5% by weight (meaning at least 75%) Up to 25% of other possible isomers), up to 100% (i.e. 100% of one isomer, without other isomers) of compounds, starting materials or reagents, preferably a compound having a stereoisomer excess of from 75% up to 100%, starting materials or reagents, more preferably having a stereoisomer of from 15% to up to 100% of the compound, starting material or The reagent, more preferably a compound or intermediate having a stereoisomeric excess of from 94% up to 1% by weight, and most preferably has a stereoisomeric excess of from 97% up to 100%. "The terminology of pure, and, and diastereomeric soils should be understood in a similar manner, but it is an individual excess of 2〇 in the discussion. An excess of the image. Although, although a method for preparing a pure compound on the stereoisomer of the formula (7) according to the present invention, a stereoisomerically pure starting material can be advantageously employed, but it is generally expected to be applied by application. The purification procedure is known to further purify the compound and the intermediate. For example, the palmo isomer can be obtained by its diastereoisomer-14-1323260 A7 B7 5. The invention (13) the selectivity of the salt and the optically active acid Separation from each other by crystallization. Alternatively, the palmomer isomer can be separated by a chromatographic technique using a palm stationary phase. Although hexahydro-furo[2,3-b]furan-3-ol has three stereo The original center, and in theory the fact that eight different stereoisomers should appear, but only four stereoisomers are considered to exist. This is due to the bicyclic ring structure in hexahydro-furan [2,3- b] caused by the rigidity of furan-3-ol, which causes its trans-fused stereo Weng is thermodynamically unfavorable. Only stereoisomers with a cis-fused configuration are thermodynamically stable, thus reducing the stereo hexahydro-furo[2,3-b]furan-3-ol The number of isomers becomes the following: 5

10 化合物 組態 原子3 組態 原子3a 組態 原子6a 立體化學 描述符號 7.1 R S R (3R,3aS,6aR) 7.2 R R S (3R,3aR,6aS) 7.3 S R S (3S,3aR,6aS) 7.4 S S R (3S,3aS,6aR) 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 15 本發明之方法可參考圖式1而更為明瞭,其中P1與P2各 獨立表示氫、羥基保護基,或可一起形成毗二醇保護基, R1表示烷基、芳基或芳烷基,R2表示氫或COOR3,R3表示 烷基、芳基或芳烷基,或R3,若存在時,與R1和彼等所 連接之原子一起採用,可形成6至8-員環狀基團,其可視 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(μ) 情況被烷基、芳基或芳烷基取代;且R4表示烷基。 圖式1描繪一種合成方法,用以合成六氫-呋喃并[2,3-b] 呋喃-3-醇(7),以式(1)中間物開始,其中,P1與P2各獨立 表示氫、羥基保護基,或可一起形成毗二醇保護基。 5 上文所提及之羥基保護基與毗二醇保護基,可容易地藉 由此項技藝中已知之方法而分裂,譬如水解作用、還原作 用等,且依所使用之保護基而定,經適當地選擇。拫據-更-佳具體實施例,毗二醇保護基係為酸不安定性保護基,其 中”酸不安定性"一詞,於本文中使用時,係指容易使用 10 酸性條件分裂之田比二醇保護基。 圖式110 Compound Configuration Atomic 3 Configuration Atom 3a Configuration Atomic 6a Stereochemical Description Symbol 7.1 RSR (3R, 3aS, 6aR) 7.2 RRS (3R, 3aR, 6aS) 7.3 SRS (3S, 3aR, 6aS) 7.4 SSR (3S, 3aS, 6aR) Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed 15 The method of the present invention can be more clearly understood by referring to Figure 1, wherein P1 and P2 each independently represent hydrogen, a hydroxyl protecting group, or may form a diol protection together. R1 represents an alkyl group, an aryl group or an aralkyl group, R2 represents hydrogen or COOR3, R3 represents an alkyl group, an aryl group or an aralkyl group, or R3, if present, together with R1 and the atoms to which they are attached It can form a 6 to 8-membered cyclic group, which can be applied to the Chinese National Standard (CNS) A4 specification (210x297 mm) according to the paper scale. 1323260 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed A7 B7 V. Invention Description ( μ) is substituted by an alkyl group, an aryl group or an aralkyl group; and R4 represents an alkyl group. Scheme 1 depicts a synthetic procedure for the synthesis of hexahydro-furo[2,3-b]furan-3-ol (7) starting with an intermediate of formula (1) wherein P1 and P2 each independently represent hydrogen. a hydroxy protecting group, or may together form a diol protecting group. 5 The hydroxy protecting group and the contigyl diol protecting group referred to above may be readily cleaved by methods known in the art, such as hydrolysis, reduction, etc., depending on the protecting group employed, Appropriately selected. In accordance with the preferred embodiment, the diol protecting group is an acid labile protecting group, wherein the term "acid unstable", as used herein, refers to a field that is easier to split using 10 acidic conditions. Glycol protecting group. Figure 1

_Ni_f反應 i)鹼 OH ii)酸 6 OR" 環化 -16- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(15) 於本發明中使用之數種經保護之式⑴丙二羥醛,係為 已知化合物。合成此等經保護丙二羥醛衍生物之對掌選擇 性以及外消旋變型,已被描述於文獻中。例如,2,3_0亞 異丙基-S-丙二羥醛之製備,係描述Hubschwerlen,合成, 5 1986,962中’ 2’3-0·亞異丙基-R-丙二羥醛之製備,係描述於 C. R_ Schmid 等人,J. Org. Chem. 1"1,56, 4〇56_4〇58 中,而 2,3_〇_ 亞異丙基-(R,S)-丙二羥發之製備,係描述於八以打等人, Tetrahedron Lett. 1998, 39, Η37·144〇 中。該式⑴中間物可市購 而得,或在反應之前製成,或當場形成。根據較佳具體實 10 施例’該化合物係當場形成。 在製備式⑺化合物之較佳方法之第一個步驟中,式(2) 1石-不飽和酯係經由與適當氧基羰基亞曱基試劑之縮合 反應’於適當溶劑存在下’在適當溫度下,製自式⑴中 間物。 經濟部智慧財產局員工消费合作社印製 15 一般而言’在式⑴起始物質中引進=C(R2)C(=0)〇Ri部份 基團之任何反應程序,均可利用。例如,式(1)中間物成 為式(2)中間物之此種轉化,可使用一種利用式CHR2R5_ c(=0)or1之氧基羰基亞曱基部份基團之反應程序進行,例 如經由Wittig反應,使用式(R6 )3 P=CR2 -CPCOOR1之磷亞烧 20 基化合物;經由Homer-Emmons反應,使用式(R7 〇)2 CHR ((=0)01^1之膦酸酯,於鹼存在下;或經由Kn〇evenagel 型縮合反應,使用式R1 0C(=0)-CHR2 -(:(=0)0111之丙二酸酯 衍生物,於鹼存在下,其中R1、R2、R6及R7均具有如上 文所定義之相同意義。另一種替代方式,可使用Ref〇rmatsky -17- 本纸張尺度適用中國图家標準(CNS)A4規格(210x297公爱) 1323260 A7 B7 五、發明說明(16) 試劑,譬如氧基羰基亞曱基鋅鹵化物。又另一種替代方式 係涉及使用-C(=0)-0-部份基團之先質,譬如氰化物。此等 類型之反應程序,係詳細描述於JerryMarch之高等有機化 學手冊中。 5 根據較佳具體實施例,該氧基羰基亞曱基試劑係選自包 括(烷氧羰基亞甲基)磷烷,例如(乙氧羰基亞甲基)三苯基 -磷烷、(曱氧羰基亞曱基)-三苯基磷烷、(乙氧羰基亞曱基) 三甲基磷烷、(乙氧羰基亞甲基)-三乙基磷烷、(乙氧羰基 亞曱基)三環己基磷烷或(乙氧羰基亞甲基)三丁基磷烷;烷 10 基二烷基膦酸基醋酸酯與烷基二芳基膦酸基醋酸酯,例如 膦酸基醋酸三乙酯、二甲基膦酸基醋酸乙酯、二乙基膦酸 基醋酸曱酯或二苯基-膦酸基醋酸乙酯Γ烷基丙二酸酯類 ,例如丙二酸二曱酯、丙二酸二乙酯、丙二酸二-第三-丁 酯及丙二酸環狀亞異丙基酯。 15 適當鹼之實例,包括但不限於烷基胺類與芳族胺類,譬 經濟部智慧財產局員工消費合作社印製 如:σ比咬、四氫σ比σ各、六氫°比σ定、嗎福°林、N-甲基嗎福 咁、1,4-二氮雙環并[2.2.2]辛烷(DABCO)、1,3-二氮雙環并[3.4.0] 壬-5-烯(DBN)、1,8-二氮雙環并[5.4.0] +—-7-烯(DBU)、Ν,Ν-二乙基苯胺、Ν,Ν-二甲胺基吡啶、喳啡、三乙胺及Ν,Ν-二 20 異丙基乙胺;以及鈉-、鉀-或鋰氫化物;鈉-、斜7、鋰-或铯碳酸鹽;鈉-、鉀-、鋰-或铯碳酸鹽與烷氧化物鹼, 譬如鈉、鋰或鉀之曱氧化物、乙氧化物、丁氧化物、第三 -丁氧化物及第三-戊氧化物;丁基鋰與鋰二異丙基胺。 供此反應用之適當溶劑,係為此項技藝中已知用於縮合 -18- 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(17) 反應之任何烴 '醚、鹵化烴或芳族溶劑。其係包括位不限 於戊烷 '己烷、庚烷、甲苯、二甲笨類、苯 '三甲笨類、 第三-丁基甲基醚、二烷基醚類(乙基、丁基)、二笨基韃 、氯笨、二氣曱烧、氯仿、四氯化奴、乙腈、一氣笨、二 5氯乙烷、三氣乙烷、環己烷、醋酸乙酯、醋酸異丙酯、四 氫呋喃、二氧陸園、甲醇、乙醇及異丙醇。 若採用Knoevenagel髮之縮合’則亦可合宜地使用酸軒, 譬如醋酸酐,在此縮合反應中作為脫水劑。水自反應媒質 移除之事實,將推遂反應之平衡朝向<2,,不飽和二能, 10而造成反應完全。醋酸酐可被四氫呋喃、N-曱基-嗎福咐 或醋酸異丙酯取代。添加驗可增加Knoevenagel反應之產率 。實例包括使用烷基胺類,譬如三乙胺。此種鹼較佳係以 少里添加。或者,Knoevenage丨反應可使用TiCI4進行。 15 此縮合反應之適當溫度範圍,係在室溫與適當溶劑 流溫度之間,此為一種容易地由熟諳有機合成技藝二 之條件。較佳係在室溫下操作此反應。 卜、 經濟部智慧財產局員工消费合作社印製 20 依縮合反應之類型及所使用之試劑而定,可合成出弋⑺ 之α,心不飽和單酯類(當R2 = H時)或式⑺之^,心不飽 二醋類(當卜CO⑽時)。式(2)之α,^不飽和單酷類 醋類,其中R%Rl為不同,可以環繞雙鍵£或 z之立體化學獲得。E/Z異構物比例係依所應用之縮合試 劑μ反應條件而定,特別是反應溶劑。 瑞其^㈣方法之下㈣’係包括將作為甲醯基先質之 土甲院,添加至式(2) 不飽和賴中間物中於適當 -19- 本紙張尺度賴+ @ 0⑤準(CNS)A4規;297公釐) 1323260 A7 B7 五、發明說明(18) 鹼存在下,造成式(3)之1,4-加成產物。此硝基甲烷加成步 驟係以非對映異構選擇性方式發生。在戊酸酯骨架之碳原 子數3(C-3)處新形成之立體中心,係被碳原子數4(C-4)之 氧化位置處之立體化學所控制。_Ni_f reaction i) alkali OH ii) acid 6 OR" cyclization-16- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1323260 A7 B7 V. Invention Description (15) In the present invention Several protected propylene dialdehydes of the formula (1) are used as known compounds. The palm-selective and racemic variants for the synthesis of such protected propylene dialdehyde derivatives have been described in the literature. For example, the preparation of 2,3_0 isopropylidene-S-propanedialdehyde is described in Hubschwerlen, Synthesis, 5 1986, 962 Preparation of '2'3-0·isopropylidene-R-propanedialdehyde , described in C. R_Schmid et al., J. Org. Chem. 1"1, 56, 4〇56_4〇58, and 2,3_〇_isopropylidene-(R,S)-propane The preparation of hydroxy hair is described in Ba Yi et al., Tetrahedron Lett. 1998, 39, Η 37·144〇. The intermediate of the formula (1) is commercially available or may be prepared prior to the reaction or formed on the spot. According to a preferred embodiment, the compound is formed on the spot. In the first step of the preferred process for the preparation of a compound of formula (7), the phospho-unsaturated ester of formula (2) is subjected to a condensation reaction with a suitable oxycarbonylhydrazolyl reagent in the presence of a suitable solvent at a suitable temperature. Next, the intermediate from the formula (1). Printing by the Intellectual Property Office of the Ministry of Economic Affairs, Employees' Consumption Cooperatives 15 In general, any reaction procedure that introduces the =C(R2)C(=0)〇Ri group in the starting material of formula (1) can be utilized. For example, the conversion of the intermediate of formula (1) to the intermediate of formula (2) can be carried out using a reaction procedure using an oxycarbonylhydrazino moiety of formula CHR2R5_c(=0)or1, for example via Wittig reaction, using a phosphorus-burning 20-based compound of the formula (R6)3P=CR2-CPCOOR1; via a Homer-Emmons reaction, using a phosphonate of the formula (R7 〇) 2 CHR ((=0)01^1, In the presence of a base; or via a Kn〇evenagel type condensation reaction, a malonic ester derivative of the formula R1 0C(=0)-CHR2 -(:(=0)0111 is used, in the presence of a base, wherein R1, R2, R6 And R7 have the same meaning as defined above. Another alternative is to use Ref〇rmatsky -17- This paper scale applies to China National Standard (CNS) A4 specification (210x297 public) 1323260 A7 B7 V. Invention Description (16) Reagents, such as oxycarbonyl-indenyl zinc halides. Yet another alternative involves the use of a precursor of the -C(=0)-0- moiety, such as cyanide. The reaction procedure is described in detail in the Advanced Organic Chemistry Handbook by Jerry March. 5 According to a preferred embodiment, the oxycarbonyl fluorenylene test Is selected from the group consisting of (alkoxycarbonylmethylene)phosphorane, such as (ethoxycarbonylmethylene)triphenyl-phosphane, (曱 oxycarbonylhydrazino)-triphenylphosphane, (ethoxycarbonyl) Mercapto) trimethylphosphane, (ethoxycarbonylmethylene)-triethylphosphane, (ethoxycarbonylhydrazino)tricyclohexylphosphane or (ethoxycarbonylmethylene)tributyl a phosphine; an alkyl 10 -dialkylphosphonic acid acetate and an alkyl diarylphosphonic acid acetate, such as triethyl phosphonate, ethyl dimethyl phosphonate, diethyl phosphonic acid Ethyl acetate or diphenyl-phosphonate ethyl acrylate alkyl malonate, such as dinonyl malonate, diethyl malonate, di-tert-butyl malonate and Malonic acid cyclic isopropylidene ester 15 Examples of suitable bases, including but not limited to alkylamines and aromatic amines, printed by the Intellectual Property Office of the Ministry of Economic Affairs, employee consumption cooperatives such as: σ bite, tetrahydrogen σ ratio σ, hexahydrogen ratio σ set, 福福°林, N-methylmorphine, 1,4-diazabicyclo[2.2.2]octane (DABCO), 1,3-diazepine Bicyclo[3.4.0]non-5-ene (DBN), 1,8-diazabicyclo[5.4 .0] +-7-ene (DBU), hydrazine, hydrazine-diethylaniline, hydrazine, hydrazine-dimethylaminopyridine, morphine, triethylamine and hydrazine, hydrazine-di-20 isopropylethylamine And sodium-, potassium- or lithium hydride; sodium-, slant 7, lithium- or cesium carbonate; sodium-, potassium-, lithium- or strontium carbonate and alkoxide bases, such as sodium, lithium or potassium Cerium oxide, ethoxylate, butoxide, third-butoxide and third-pentoxide; butyl lithium and lithium diisopropylamine. Suitable solvents for this reaction are known in the art for condensation -18- This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm) 1323260 A7 B7 V. Description of invention (17) Any hydrocarbon 'ether, halogenated hydrocarbon or aromatic solvent of the reaction. The system includes, but is not limited to, pentane 'hexane, heptane, toluene, dimethyl benzene, benzene 'trimethyl phenylene, third-butyl methyl ether, dialkyl ether (ethyl, butyl), two stupid Base, chloroform, dioxane, chloroform, tetrachloronyl, acetonitrile, gas, bi- 5, ethyl chloride, tri-ethane, cyclohexane, ethyl acetate, isopropyl acetate, tetrahydrofuran, Oxygen, methanol, ethanol and isopropanol. If a condensation of Knoevenagel is used, it is also convenient to use an acid hydrazine, such as acetic anhydride, as a dehydrating agent in this condensation reaction. The fact that water is removed from the reaction medium shifts the equilibrium of the push reaction toward <2, unsaturated two energy, and 10 causes the reaction to be complete. The acetic anhydride can be substituted with tetrahydrofuran, N-mercapto-isfosone or isopropyl acetate. Addition can increase the yield of the Knoevenagel reaction. Examples include the use of alkylamines such as triethylamine. Such a base is preferably added in a small amount. Alternatively, the Knoevenage(R) reaction can be carried out using TiCI4. 15 The appropriate temperature range for this condensation reaction is between room temperature and the temperature of the appropriate solvent stream, which is a condition readily achievable by the organic synthesis technique. It is preferred to operate the reaction at room temperature. Bu, Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, Printing 20 Depending on the type of condensation reaction and the reagents used, it is possible to synthesize α(7) α, heart-unsaturated monoesters (when R2 = H) or formula (7) ^, heart is not full of vinegar (when Bu CO (10)). The α, ^ unsaturated single type vinegar of the formula (2), wherein R% Rl is different, can be obtained by stereochemistry around the double bond £ or z. The E/Z isomer ratio depends on the reaction conditions of the condensation reagent used, particularly the reaction solvent. Under the method of Ruiqi^(4)(4), the system includes the soil of the scorpion-based precursor, added to the formula (2) in the unsaturated lysate intermediate at the appropriate -19- paper scale 赖+ @ 05准(CNS ) A4 gauge; 297 mm) 1323260 A7 B7 V. Description of the invention (18) In the presence of a base, a 1,4-addition product of formula (3) is produced. This nitromethane addition step occurs in a diastereoselective manner. The newly formed stereocenter at the carbon number 3 (C-3) of the valerate skeleton is controlled by the stereochemistry at the oxidation position of the carbon number 4 (C-4).

經濟部智慧財產局員工消費合作社印製 同側/對側比例係進一步藉由α,/5-不飽和酯(2)之類型 (Ε或Ζ,單-或二-酯),所使用鹼之類型,及反應條件, 10 譬如反應溶劑與反應溫度,而加以控制。通常主要為同側 加成產物。 適當鹼之實例,包括但不限於DBN(1,3=二氮雙環并[3.4.0] 壬_5_烯)與DBU(1,8-二氮雙環并[5_4.0]十一 _7_烯)、三乙胺、 四氫°比°各、六氫吡咬、嗎福D林、N-曱基嗎福π林、1,4-二氮 15 雙環并[2.2.2]-辛烷(DABCO)、二曱胺基吡啶(DMAP)、氫氧 化鈉、氫氧化鉀、氫氧化鋰、氫氧化鈣、氫氧化鋇、碳酸 納、碳酸鉀、氫化納、氫化斜、曱醇納、曱醇裡、乙醇鈉 、乙醇鉀、第三-丁醇鋰、第三-丁醇’納、第三-丁醇鉀、 氟化四丁基銨、氫氧化四丁基銨。適當溶劑之實例包括但 20 不限於戊烷、己烷、庚烷、曱苯 '二曱苯類、苯;三曱苯 類、第三-丁基-甲基醚、二烷基醚類(乙基、丁基)、二苯 基醚、氣苯、二氣曱烷、氣仿、四氣化碳、乙腈、二氯苯 、1,2-二氣乙烷與1,1,1-三氣乙烷、環己烷、四氫呋喃、二 氧陸圜、甲醇、乙醇、異丙醇、二曱亞颯(DMSO)、二曱 -20- 本纸張尺度適用中國圉家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(19) 基曱醯胺(DMF)、N-曱基四氣吼略綱^Mp)。反應溫度係 設定在約0至約赋之範圍内,較佳係在約1〇至約耽之 範圍内,更佳係在約室溫下。 式⑶中間物可替代地藉由—種包括以下步驟之方法製 5成,首先使式⑴中間物與硝基甲院縮合,而造成式⑻中 間物,其次,使該式⑻中間物與式chr2r8_c(=〇)〇r1之適 當氧基m基亞T基試财應,而造成喊⑶十間曹。 應明瞭的是’熟諳此藝者可採用其他技藝上已知之反應 程序,自式⑴中間物開始,以達成式⑶中間物。 10在根據本發明方法中之下一步驟,係為從式⑶中間物 開始,以形成式⑹中間物。 達成此目的之一種方式,係涉及經由Nef反應,使式⑶ 中間物轉變成其相應之甲醯基衍生物。此步驟係經由首先 以鹼,然後以強酸處理式(3)中間物而進行,造成式⑷與(4,) 15中間物。 經濟部智慧財產局員工消費合作社印製The ipsilateral/contralateral ratio printed by the Intellectual Property Office of the Intellectual Property Office of the Ministry of Economic Affairs is further based on the type of α,/5-unsaturated ester (2) (Ε or Ζ, mono- or di-ester), the base used. The type, and the reaction conditions, 10 are controlled, for example, by the reaction solvent and the reaction temperature. Usually mainly the ipsilateral addition product. Examples of suitable bases include, but are not limited to, DBN (1,3 = diazabicyclo[3.4.0] 壬_5_ene) and DBU (1,8-diazabicyclo[5_4.0] 十一_7 _ene), triethylamine, tetrahydrogen ratio, hexahydropyrazole, chloroform D, N-mercapto ruthenium π, 1,4-diaza 15 bicyclo[2.2.2]-octyl Alkane (DABCO), diammonium pyridine (DMAP), sodium hydroxide, potassium hydroxide, lithium hydroxide, calcium hydroxide, barium hydroxide, sodium carbonate, potassium carbonate, sodium hydride, hydrogenated slant, sodium sterol, In the sterol, sodium ethoxide, potassium ethoxide, lithium tributoxide, tris-butanol 'n, potassium tert-butoxide, tetrabutylammonium fluoride, tetrabutylammonium hydroxide. Examples of suitable solvents include, but are not limited to, pentane, hexane, heptane, indole benzene diterpenic benzene, benzene, triterpene benzene, tert-butyl-methyl ether, dialkyl ether (B Base, butyl), diphenyl ether, gas benzene, dioxane, gas imitation, carbon tetrachloride, acetonitrile, dichlorobenzene, 1,2-diethane and 1,1,1-trigas Ethane, cyclohexane, tetrahydrofuran, dioxane, methanol, ethanol, isopropanol, dioxins (DMSO), diterpenoid-20- This paper scale applies to China National Standard (CNS) A4 specification ( 210x297 mm) 1323260 A7 B7 V. INSTRUCTIONS (19) Baseline amines (DMF), N-mercaptos. The reaction temperature is set in the range of from about 0 to about 10,000 Å, preferably in the range of from about 1 Torr to about Torr, more preferably at about room temperature. The intermediate of formula (3) may alternatively be prepared by a method comprising the following steps: first, the intermediate of formula (1) is condensed with a nitrile, thereby causing an intermediate of formula (8), and secondly, the intermediate of formula (8) is Chr2r8_c (= 〇) 〇 r1 of the appropriate oxy m-based sub-T-based test should be made, and caused by shouting (3) ten Cao. It should be understood that those skilled in the art may use other process known in the art to begin with the intermediate of formula (1) to achieve the intermediate of formula (3). 10 In the next step in the process according to the invention, starting from the intermediate of formula (3) to form an intermediate of formula (6). One way to achieve this is to convert the intermediate of formula (3) to its corresponding indolyl derivative via a Nef reaction. This step is carried out by first treating the intermediate of formula (3) with a base and then a strong acid, resulting in an intermediate of formula (4) and (4,) 15. Ministry of Economic Affairs, Intellectual Property Bureau, employee consumption cooperative, printing

Nef反應通常被定義為一級或二級硝基烧轉化成其相應 之羰基化合物(N. Komblum有機反應1962, I2, 101與H. W. ?^11^1^有機反應1990,38,655)。在古典程序中,係將硝基烧 以鹼在硝基官能基之位置去質子化,接著為中間物”氮 2〇 氧化物"鹽’經由添加至以過量存在之強酸中之酸催化水 解作用,獲得羰基衍生物。 適當鹼可由熟諳有機合成技藝者加以選擇。適當鹼包括 但不限於無機鹼,譬如鹼金屬、鹼土金屬及銨之氫氧化物 與烷氧化物。適當鹼亦包括但不限於金屬胺化物與烷基經 -21 - 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(20) 。適當強鹼之實例為鋰二異丙基胺、鈉胺、曱醇鈉、第三 -丁醇鉀、丁醇鈉、氫氧化鈣、氫氧化鋇、甲基鋰、丁基 鋰、己基鋰、苯基鋰及氫氧化四級烷基銨、DBN(1,3-二氮 雙環并[3_4.0]壬-5-烯)與DBU (1,8-二氮雙環并[5.4.0]十一 -7-烯) 5 、1,4-二氮雙環并[2.2.2]辛烷(DABCO)、碳酸鉀、碳酸鈉。 於本文中使用之"強酸"一詞,係指任何習用強酸,譬如 強無機酸類,例如鹽酸與’疏:酸,及強有機酸類,例如苯磺 酸與三氣醋酸。較佳強酸為濃硫酸或鹽酸。 強酸之使用會造成酸不安定性保護基之去保護作用,因 10 此形成二镎中間物,其中一級醇會與甲醯基縮合成下式環 狀半縮醛The Nef reaction is generally defined as the conversion of a primary or secondary nitro group to its corresponding carbonyl compound (N. Komblum Organic Reaction 1962, I2, 101 and H. W. ?^11^1^ Organic Reaction 1990, 38, 655). In the classical procedure, the nitro group is deprotonated with a base at the position of the nitro function, followed by the acid catalyzed hydrolysis of the intermediate "nitrogen 2 〇 oxide" salt added to the strong acid present in excess. The carbonyl derivative is obtained. Suitable bases can be selected by those skilled in the art of organic synthesis. Suitable bases include, but are not limited to, inorganic bases such as alkali metal, alkaline earth metal and ammonium hydroxides and alkoxides. Suitable bases also include but not Limited to metal amides and alkyl groups - 21 - This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm) 1323260 A7 B7 5. Inventive Note (20). An example of a suitable strong base is lithium diisopropyl. Base amine, sodium amine, sodium decoxide, potassium third potassium butoxide, sodium butoxide, calcium hydroxide, barium hydroxide, methyl lithium, butyl lithium, hexyl lithium, phenyl lithium and tetraalkyl hydroxide Ammonium, DBN (1,3-diazabicyclo[3_4.0]non-5-ene) and DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) 5,1, 4-diazabicyclo[2.2.2]octane (DABCO), potassium carbonate, sodium carbonate. The term "strong acid" is used herein. Means any conventional strong acid, such as strong inorganic acids, such as hydrochloric acid and 'salt: acid, and strong organic acids, such as benzenesulfonic acid and tri-acetic acid. The preferred strong acid is concentrated sulfuric acid or hydrochloric acid. The use of strong acid will cause acid instability. The deprotection of the protecting group, as a result of the formation of a diterpene intermediate, wherein the primary alcohol is condensed with the carbenyl group to form the cyclic hemiacetal of the formula

經濟部智慧財產局員工消費合作社印製 15 使用無水條件與醇溶劑,譬如曱醇或乙醇(一般性地表 示為R4-OH),則替代地獲得曱醯基之環狀曱基縮醛或乙基 縮醛。除了此古典鹼/酸程序之外,Nef-轉化可使用此項 技藝中已知之極多種氧化以及還原劑達成。根據一項較佳 具體實施例,適當醇溶劑係選自包括曱醇、乙醇及異丙醇。 20 該Nef反應可在溫度範圍介於約-7 8 °C與約5 5 °C乏_間進行 ,較佳溫度係位於約-18°C與約室溫之間。反應時間範圍 可高達約24小時,而適當範圍介於約1小時與約24小時之 間。 根據較佳具體實施例,係將式(3)中間物以鹼處理,接 -22- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(21 ) 著添加至濃強酸醇性溶液中,導致式(3)中間物之硝基甲 烷基團轉化成甲醯基。同時,此酸處理亦會催化保護基P1 與P2之分裂,而造成分子内縮醛形成,導致式⑷與(4’)中 間物。在式(4)與(4’)中間物内之R4取代基,係源自於醇R4-5 OH。 式(4)雙環狀中間物係為來自式⑶中間物之所預期反應 產物,呈同側組態,而式(4’)中間物係為來自式(3)中間物一 之所預期反應產物,呈對側組態。在式(4’)中間物之四氫 呋喃環上之碳原子數3 (C-3)與碳原子數4 (C-4)處之取代基 10 之反式組態,會阻止第二個内酯環形成,如在式(4)中間 物内之情況。Printed by the Intellectual Property Office of the Ministry of Economic Affairs, Employees' Consumption Cooperatives 15 Using anhydrous conditions with an alcohol solvent such as decyl alcohol or ethanol (generally denoted as R4-OH), a thiol-based cyclic acetal acetal or B is alternatively obtained. Acetal. In addition to this classical base/acid procedure, Nef-conversion can be achieved using a wide variety of oxidation and reducing agents known in the art. According to a preferred embodiment, the appropriate alcohol solvent is selected from the group consisting of decyl alcohol, ethanol and isopropanol. 20 The Nef reaction can be carried out at a temperature ranging from about -78 ° C to about 55 ° C, preferably at a temperature between about -18 ° C and about room temperature. The reaction time can range up to about 24 hours with a suitable range between about 1 hour and about 24 hours. According to a preferred embodiment, the intermediate of the formula (3) is treated with a base, and the paper size is applied to the Chinese National Standard (CNS) A4 specification (210 X 297 mm). 1323260 A7 B7 5. Invention Description ( 21) Addition to a strong acid alcoholic solution results in the conversion of the nitromethyl group of the intermediate of formula (3) to the formazan group. At the same time, this acid treatment also catalyzes the splitting of the protecting groups P1 and P2, resulting in the formation of intramolecular acetals, resulting in intermediates of formulas (4) and (4'). The R4 substituents in the intermediates of formula (4) and (4') are derived from the alcohol R4-5 OH. The bicyclic intermediate of formula (4) is the expected reaction product from the intermediate of formula (3), which is in the same side configuration, and the intermediate of formula (4') is the expected reaction from the intermediate of formula (3). Product, in contralateral configuration. The trans configuration of the substituent 3 at the carbon atom number 3 (C-3) and the carbon number 4 (C-4) on the tetrahydrofuran ring of the intermediate of the formula (4') prevents the second lactone The ring is formed as in the case of the intermediate of formula (4).

經濟部智慧財產局員工消費合作社印製 15 在合成程序之此階段下,當R2為COOR3時,係施行脫羧 步驟。該脫羧步驟包括移除式(4)與(4〇中間物中之-C(=0)-OR3。在一較佳具體實施例中,脫羧步驟係經由以適當鹼 ,譬如氫氧化鈉或氫氧化鉀,處理式(4)與(4,)中間物,在 20 加熱條件下施行,於酸化作用後,個別造成式(5)與(5’)中 間物。同時,在式(4,)中間物中之R1,係被氫置換,正如 可在中間物(5,)之化學式中所發現者。 式(5)雙環狀内酯衍生物,係為來自式(4)中間物之所預 期反應產物,而式(5〇羧酸衍生物係為來自式(4’)中間物之 -23- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(22) 所預期反應產物。在式(5,)中間物之四氫呋喃環上之C-3與 C-4處之取代基之反式組態,會阻止第二個内酯環形成, 如在式(5)中間物中之情況。 在合成程序之此階段下,中間物⑷與(4’)或中間物(5)與 5 (5’),可使用技藝上已知之層析技術互相分離。除了層析 技術以外,式(5·)中間物可利用酸/鹼萃取,而與式(5)内 酯分離。典型上,式(5’)中間物可以驗性水溶液,譬如碳 酸氫鈉溶液,萃取自式(5)與(5*)中間物在有機非水可溶混 溶劑中之混合物。適當有機非水可溶混溶劑係為任何烴、 10 醚、鹵化烴或芳族溶劑。其包括但不限於戊烷、己烷、庚 烷、甲笨、二曱苯類、苯、三曱笨類、第三-丁基曱基醚 、二烧基_類(乙基、丁基)、二苯基醚、氣苯、二氣甲烧· 、氣仿、四氣化碳、乙腈、二氣苯、1,2-二氣乙烷、1,1,1-三氣乙烷、醋酸乙酯及醋酸異丙酯。 15 為改良親脂性化合物之萃取產率,可在萃取之前,將水 溶性鹽添加至混合物中。較佳鹽包括NaCl。添加水可溶混 之鹽,可增加萃取之產率。 或者,可使用中間物(4)與(4’),或中間物(5)與(5)之混 經濟部智慧財產局員工消費合作社印製 合物,而無需進一步分離,特別是當其以立體選擇性方式 20 合成時。 在下列步驟中,係將式(4)及/或(4')中間物,其中R2為 氫,或將式(5)及/或(5,)中間物,以適當還原劑還原,而 造成式⑹中間物。 此還原步驟可合宜地經由以金屬氫化物,譬如硼烷複合 -24- 本纸張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(23) 物、二硼烷、硼氫化鋰、硼氩化鈉-LiCl、氫化二異丁基叙 或氫化鋰鋁,在適當無水溶劑中,處理式(4)及/或(4,), 其中R2為氫,或(5)及/或(5·)中間物而達成。適當無水溶 劑之實例,包括但不限於二氣曱烷、甲笨、二甲笨、笨、 戊烷、己烷、庚烷、輕油醚、1,4-噻4烷、乙醚、二異丙 基趟、四氮β夫喃、1,4_二氧陸圜、I,2·二曱氧基乙燒,且 一般而言,係為容易接受被使用於利用上文所引述試劑之 化學還原方法中之任何無水溶劑。該還原步驟可在範圍介 於約-78°c與約55°C間之溫度下進行,較佳溫度係位於約_18 °C與約室溫之間。反應時間範圍可涵蓋至高達約24小時, 且適當地在約2與約24小時之間改變。根據一項較佳具體 實施例,還原步驟係使用硼氫化鋰在四氫呋喃中施行。或 者,還原作用可使用催化氫化作用達成。催化氫化作用可 適當地使用H2且併用金屬,包括Μ、Pt、Ni及碳施行。 15 經濟部智慧財產局員工消費合作社印製 若R2為氫,則可在從.式⑶中間物製備式⑹中間物之中 ,按照替代途徑。在此兩種替代方式之任何一種中,係採 用Nef程序。因此,式(3)中間物轉化成式(6)中間物,可替 代地藉由包括以下步驟之方法進行,首先以適當還原劑, 使式(3)中間物還原,造成式(9)中間物,其次使所獲得之 式(9)中間物接受Nef反應,其方式是以鹼,然後以強酸處 理而造成式⑹中間物。 最後步驟包括藉由環化反應,使式⑹中間物轉化成所 要之式⑺化合物。此環化反應係經由分子内縮醛化交換 反應發生’並可以任何酸可相容之有機溶劑或水可混溶劑 -25-本紙張尺度適用中國固家標準(CNS)A4規格(210 X 297公« ) 1323260 發明說明(24 與水之組合’且於強有機或無機酸存在下進行。該反應係 適當地經由以催化量之強酸處理式⑹中間物,以施行之 ^-較佳具體實施例中,強酸係選自包括舰與硫酸。 該環化步驟可在範圍介於約_78<t與約坑間之溫度下進行 ,較佳溫度係位於約_18°c與約室溫之間。 上述化合物與中間物之純立體異構形式,可藉由該上述 合成程序合成。例如’將採麟掌異構上純之起始物質。 根據較佳具體實關,該上述方法係適詩製備式(71) 之(311,333加11)六氫_吱喃并[2,3_15]吱喃_3_醇Printed by the Intellectual Property Office of the Ministry of Economic Affairs and the Consumer Cooperatives. 15 At this stage of the synthesis process, when R2 is COOR3, the decarboxylation step is performed. The decarboxylation step comprises removing -C(=0)-OR3 in the intermediate of formula (4) and (4). In a preferred embodiment, the decarboxylation step is via a suitable base such as sodium hydroxide or hydrogen. Potassium oxide, treating intermediates of formula (4) and (4,), is carried out under heating conditions of 20, and after acidification, the intermediates of formula (5) and (5') are separately produced. Meanwhile, in formula (4,) R1 in the intermediate is replaced by hydrogen, as found in the chemical formula of the intermediate (5,). The bicyclic lactone derivative of the formula (5) is derived from the intermediate of the formula (4). The reaction product is expected, and the formula (5 carboxylic acid derivative is from the intermediate of the formula (4') -23- This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1323260 A7 B7 (22) The desired reaction product. The trans configuration of the substituents at C-3 and C-4 on the tetrahydrofuran ring of the intermediate of formula (5,) prevents the formation of the second lactone ring. , as in the case of the intermediate of formula (5). At this stage of the synthesis procedure, intermediates (4) and (4') or intermediates (5) and 5 (5'), a layer known in the art can be used. The separation techniques are separated from each other. In addition to the chromatographic technique, the intermediate of formula (5.) can be extracted by acid/base and separated from the lactone of formula (5). Typically, the intermediate of formula (5') can be used as an aqueous solution. For example, a sodium bicarbonate solution is extracted from a mixture of intermediates of formula (5) and (5*) in an organic non-aqueous miscible solvent. Suitable organic non-aqueous miscible solvents are any hydrocarbon, 10 ether, halogenated hydrocarbon or Aromatic solvent, including but not limited to pentane, hexane, heptane, methyl benzene, diphenylbenzene, benzene, triterpenoid, tri-butyl decyl ether, dialkyl group (ethyl) , butyl), diphenyl ether, gas benzene, two gas combustion, gas imitation, four gasification carbon, acetonitrile, two gas benzene, 1,2-diethane, 1,1,1-three gas Ethane, ethyl acetate and isopropyl acetate. 15 To improve the extraction yield of the lipophilic compound, a water-soluble salt can be added to the mixture prior to extraction. Preferred salts include NaCl. Water-miscible salts are added. , can increase the yield of extraction. Or, you can use the intermediates (4) and (4'), or the intermediates (5) and (5) of the Ministry of Economic Affairs Intellectual Property Bureau employees consumption cooperatives Printing the composition without further separation, especially when it is synthesized in a stereoselective manner 20. In the following steps, an intermediate of formula (4) and/or (4') wherein R2 is hydrogen, or The intermediate of formula (5) and/or (5,) is reduced with a suitable reducing agent to form an intermediate of formula (6). This reduction step may conveniently be via a metal hydride such as borane complex-24-paper The scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1323260 A7 B7 V. Description of invention (23), diborane, lithium borohydride, sodium borohydride-LiCl, hydrogenated diisobutyl Or lithium aluminum hydride, in a suitable anhydrous solvent, to treat the formula (4) and / or (4,), wherein R2 is hydrogen, or (5) and / or (5) intermediates. Examples of suitable anhydrous solvents include, but are not limited to, dioxane, methyl, dimethyl, stupid, pentane, hexane, heptane, light oil ether, 1,4-thiazane, diethyl ether, diisopropyl Base, tetrazo-β-propan, 1,4-dioxanthene, I,2,2-decyloxy, and, in general, readily accepted for chemical reduction using the reagents cited above Any anhydrous solvent in the process. The reduction step can be carried out at a temperature ranging between about -78 ° C and about 55 ° C, preferably at a temperature between about -18 ° C and about room temperature. The reaction time can range up to about 24 hours, and suitably varies between about 2 and about 24 hours. According to a preferred embodiment, the reduction step is carried out using lithium borohydride in tetrahydrofuran. Alternatively, the reduction can be achieved using catalytic hydrogenation. The catalytic hydrogenation can be suitably carried out using H2 and using a metal including ruthenium, Pt, Ni and carbon. 15 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing If R2 is hydrogen, it can be used in the preparation of the intermediate of formula (6) from the intermediate of formula (3), according to an alternative route. In either of these two alternatives, the Nef program is employed. Therefore, the intermediate of formula (3) is converted into an intermediate of formula (6), alternatively by a method comprising the steps of first reducing the intermediate of formula (3) with a suitable reducing agent, resulting in the middle of formula (9) Next, the obtained intermediate of the formula (9) is subjected to a Nef reaction in the form of a base and then a strong acid to give an intermediate of the formula (6). The final step involves the conversion of the intermediate of formula (6) to the desired compound of formula (7) by a cyclization reaction. This cyclization reaction occurs via an intramolecular acetalization exchange reaction' and can be any acid compatible organic solvent or water miscible solvent-25- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297) The invention is described in the specification of (24 in combination with water) and is carried out in the presence of a strong organic or inorganic acid. The reaction is suitably carried out by treating the intermediate of the formula (6) with a catalytic amount of a strong acid. In one embodiment, the strong acid is selected from the group consisting of a ship and sulfuric acid. The cyclization step can be carried out at a temperature ranging from about _78 < t to about between pits, preferably at about -18 ° C and about room temperature. The pure stereoisomeric forms of the above compounds and intermediates can be synthesized by the above-mentioned synthetic procedures. For example, 'the starting material which is isomeric and pure to the nucleoside. According to a preferred embodiment, the above method is suitable. Preparation of (311,333 plus 11) hexahydro-indolo[2,3_15]pyran_3-alcohol of formula (71)

15 經濟部智慧財產局員工消費合作社印製 在第一個步驟中’係使式(la)中間物與如上述之適當氧 基幾基亞曱基試劑反應,而造成式(2a) α,心不飽和酿,其 中p、P 'R1及R2均具有如上文所定義之相同意義。反應 條件係與則文關於縮合步驟所述者相同。中間物(ia)可在 Knoevenagel反應之前經預熱。適當預‘溫度範圍,涵蓋4〇· 7〇C,較佳為5〇-65°C。然後,可在反應之前,使中間物冷 卻。添加試劑之順序可影嚮反應之產率。例如,使用 Knoevenagel型縮合,則可合宜地在添加脫水試劑之前,添 加氧基羰基亞曱基試劑至中間物(la)中。添加脫水試劑之 方式’可影嚮反應之產率。脫水試劑可慢慢地添加,意即 藉由配藥。添加脫水試劑後,反應可在20-60。〇範圍之溫度 26-本紙張尺度適用中國國豕標準(CNS)A4規格(210x297公爱) 1323260 A7 B7 五、發明說明(汸) 下進行,較佳係在35-55°C之範圍内。 ΏΡ215 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed in the first step 'reacts the intermediate of the formula (la) with the appropriate oxyl sulfhydryl reagent as described above, resulting in the formula (2a) α, heart Unsaturated brewing wherein p, P 'R1 and R2 have the same meaning as defined above. The reaction conditions are the same as those described in the context of the condensation step. The intermediate (ia) can be preheated prior to the Knoevenagel reaction. Properly pre-temperature range, covering 4〇·7〇C, preferably 5〇-65°C. The intermediate can then be allowed to cool before the reaction. The order in which the reagents are added can affect the yield of the reaction. For example, using a Knoevenagel type condensation, it is convenient to add an oxycarbonylhydrazino group to the intermediate (la) before adding the dehydrating agent. The manner in which the dehydrating reagent is added can affect the yield of the reaction. The dehydrating reagent can be added slowly, that is, by dispensing. After the addition of the dehydrating reagent, the reaction can be in the range of 20-60. Temperature range of 〇 26 - This paper scale applies to China National Standard (CNS) A4 specification (210x297 public) 1323260 A7 B7 5. Invention description (汸), preferably within the range of 35-55 °C. ΏΡ2

在第二個步驟中’係使該式(h)酯與硝基甲烷於適當鹼 存在下反應,造成式(3a)與(3b)中間物,其中R1、r2、pi 及P2均如上文定義。 3a N〇2In a second step, 'the ester of formula (h) is reacted with nitromethane in the presence of a suitable base to form an intermediate of formula (3a) and (3b) wherein R1, r2, pi and P2 are as defined above . 3a N〇2

經濟部智慧財產局員工消費合作社印製 反應條件係與前文關於硝基甲烷添加步驟所述者相同。 15此反應較佳係在醇性溶劑中,於非親核性鹼譬如DBU或甲 醇納存在下,在室溫下進行。依起始物質及反應條件而定 ,此步驟可以立體選擇性方式進行。 下一步驟包括經由Nef反應,使式(3a)與(3b)中間物轉變 成其相應之甲醯基衍生物。根據較佳具體實施例,係將式 20 (3a)與(此)中間物以鹼處理,接著添加至濃強酸醇性溶液 中,導致式(3a)與(3b)中間物之硝基甲烷基團轉化成甲醯 基。同時,酸處理亦會催化保護基P1與P2之分裂,造成分 子内縮醛形成,個別導致式(如)與(4,a)中間物,其中R1、 R2及R4係如上文定義。強酸醇性溶液之實例,包括硫酸 27- 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公龙) 1323260 A7 B7 ----------- 五、發明說明(26) 在CH3〇H中。在以強酸醇性溶液處理期間之溫度,係為 室溫或較低。此溫度較佳係、低於听,反應更佳係,在低於 io°c下進行。 'The Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative, Print Reaction Conditions are the same as those described above for the Nitromethane Addition Step. The reaction is preferably carried out in an alcoholic solvent at room temperature in the presence of a non-nucleophilic base such as DBU or sodium hydride. Depending on the starting materials and the reaction conditions, this step can be carried out in a stereoselective manner. The next step involves the conversion of the intermediates of formula (3a) and (3b) to their corresponding indolyl derivatives via a Nef reaction. According to a preferred embodiment, the intermediate of formula 20 (3a) and (the) is treated with a base, followed by addition to a concentrated acid alcoholic solution, resulting in a nitromethylalkyl group of the intermediates of formula (3a) and (3b). The group is converted to a formazan group. At the same time, the acid treatment also catalyzes the splitting of the protecting groups P1 and P2, resulting in the formation of acetals in the molecule, which in turn leads to intermediates of the formulae (e.g.) and (4, a), wherein R1, R2 and R4 are as defined above. Examples of strong acid alcoholic solutions, including sulfuric acid 27- This paper scale applies to China National Standard (CNS) A4 specification (210x297 male dragon) 1323260 A7 B7 ----------- V. Description of invention (26) In CH3〇H. The temperature during the treatment with the strong acid alcohol solution is room temperature or lower. This temperature is preferably below, lower than listening, and the reaction is better, at less than io °c. '

反應條件係與前文關於Nef反應所述者相同。 10 在合成程序之此階段中,當R2為COOR3時,係對式(4a) 與(4’a)中間物施行脫羧步驟。此脫羧步驟包括移除式(知) 與(4,a)中間物中之-C(=〇)-〇R3。在一較佳具體實施例中, 脫羧步驟係經由以適當鹼,譬如氫氧化鈉或氫氧化鉀,處 理式(4a)與(4’a)中間物,於加熱條件下進行,在酸化作用 15後,個別造成式(知)與(S,a)之脫羧基化產物❶同時,式(4,) 中間物中之R1,係被氫置換,造成中間物(5,a)中之羧釀部 份基團。 經濟部智慧財產局員工消費合作社印製 脫綾作用亦可使用鹵化物進行。適當試劑包括幻、Naa 、Lil、LiBr及KBr,較佳為ΚΙ。ΚΙ可溶於譬如N-甲基四 20 氫吡咯酮之溶劑中。 〜 或者’脫缓作用可在緩衝水溶液中進行。適當緩衝劑包 括檸樣酸緩衝劑,於ΡΗ = 6下。然後,在高溫下,適當地 在50°C與回流溫度之間,進行脫羧反應。反應溫度較佳係 高於80°C。 -28- 本紙張尺度家標準(CNS)A4規格(210 x 297公釐) ' -- 1323260 % A7 B7 五、發明說明(27) 經脫羧基化之混合物可使用強酸性樹脂,包括DOWEX-H+®,或溫和酸性樹脂,包括AMBERJET®中和。該樹脂亦 可用於環化反應。AMBERJET®型溫和酸性樹脂亦適合中和 此反應。 5The reaction conditions are the same as those described above for the Nef reaction. 10 In this stage of the synthesis procedure, when R2 is COOR3, the decarboxylation step is carried out on the intermediates of formula (4a) and (4'a). This decarboxylation step involves the removal of -C(=〇)-〇R3 in the intermediate of (4) and (4, a). In a preferred embodiment, the decarboxylation step is carried out by treating the intermediates of formula (4a) and (4'a) with a suitable base, such as sodium hydroxide or potassium hydroxide, under heating, in acidification 15 Thereafter, the individual is caused to form a decarboxylated product of (S, a). At the same time, R1 in the intermediate of formula (4,) is replaced by hydrogen, resulting in a carboxylation in the intermediate (5, a). Part of the group. Printing by the Intellectual Property Office of the Ministry of Economic Affairs, the Consumer Cooperatives, can also be carried out using halides. Suitable reagents include phantom, Naa, Lil, LiBr and KBr, preferably hydrazine. The hydrazine is soluble in a solvent such as N-methyltetrahydropyrrolidone. ~ or 'slowing action can be carried out in a buffered aqueous solution. A suitable buffer includes a lemon acid buffer at ΡΗ = 6. Then, at a high temperature, a decarboxylation reaction is suitably carried out between 50 ° C and reflux temperature. The reaction temperature is preferably higher than 80 °C. -28- The paper size standard (CNS) A4 specification (210 x 297 mm) ' -- 1323260 % A7 B7 V. Description of invention (27) The decarboxylated mixture can be made of strong acid resin, including DOWEX-H+ ®, or mild acid resin, including AMBERJET® Neutral. The resin can also be used in the cyclization reaction. AMBERJET® mild acid resins are also suitable for neutralizing this reaction. 5

fH 广一COOH 10 在下一步驟中,係利用層析或酸/鹼萃取,使式(4’a)中 間物,當R2為氫原子時,或式(5’a)中間物,個別與式(4a) 或(5a)中間物分離。式(4fa)或(5*a)中間物可使用技藝上已 知之方法,自反應混合物萃取,譬如使用驗性水溶液,例 如碳酸氫納溶液,在有機非水可混之溶劑中。反應係進一 15 步以已單離之式(如)或(5a)中間物進行。 中間物(5a)可使用有機溶劑進行結晶。適當溶劑包括異 丙醇、醋酸乙酯、乙醇及曱基異丁基酮。一種有利之溶劑 為異丙醇。 經濟部智慧財產局員工消費合作社印製 在下一步驟中,係以適當還原劑,使式(4a)或(5a)中間 20 物還原,造成式(6a)中間物,其中R4係如上文定義。fH 广一COOH 10 In the next step, using chromatography or acid/alkali extraction, the intermediate of formula (4'a), when R2 is a hydrogen atom, or the intermediate of formula (5'a), individual and (4a) or (5a) separation of intermediates. The intermediate of formula (4fa) or (5*a) can be extracted from the reaction mixture by methods known in the art, such as by using an aqueous test solution, such as a sodium hydrogencarbonate solution, in an organic non-aqueous miscible solvent. The reaction is carried out in a step of 15 steps in the form of an isolated (e.g.) or (5a) intermediate. The intermediate (5a) can be crystallized using an organic solvent. Suitable solvents include isopropanol, ethyl acetate, ethanol, and mercaptoisobutyl ketone. An advantageous solvent is isopropanol. Printing by the Intellectual Property Office of the Ministry of Economic Affairs, the Consumer Cooperatives In the next step, the intermediates of formula (4a) or (5a) are reduced with appropriate reducing agents to form intermediates of formula (6a), where R4 is as defined above.

-29- 本纸張尺度適用中國囷家標準(CNS)A4規格(210 X 297公釐) 五、發明說明(28) 此還原步驟可使用如前文關於還原步驟所述之相同條件 達成。根據較佳具體實施例,此步驟係使㈣氫化裡在四 氫吱喃中進行。或者’此還原作用可使駐iA丨①或NaBH4 ,於LiCl存在下進行。亦可使用催化氫化作用。催化氮化 作用可使用氫氣,於適當_存在下進行1用於催化氮 化作用之觸媒,其貫例包括錄、纪及翻。適當地,此觸媒 係存在於惰性表面上,譬如炭。 最後步驟包括藉由環化反應,使式(6a)中間物轉化成式 (7.1)化合物。此環化反應係經由分子内縮醛化交換反應發 生。戎反應較佳係經由以催化量之強酸處理式(6a)中間物 ,以進行之。在一項較佳具體實施例中,強酸係選自包括 鹽酸與硫酸。在一項具體實施例中,環祀作用係在低溫下 進行。溫度較佳係低於15°C,更佳係低於5。(:。在酸處理 後,使用適當驗,使混合物中和,並單離化合物7.^。 15 經濟部智慧財產局員工消費合作社印製 按照上述反應順序,該上述方法適用於製備式(7 2)之 (3R,3aR,6aS)六氫-咬喃并[2,3-b]吱喃-3-醇。-29- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm). V. INSTRUCTIONS (28) This reduction step can be achieved using the same conditions as described above for the reduction step. According to a preferred embodiment, this step is carried out in (4) hydrogenation in tetrahydrofuran. Alternatively, the reduction can be carried out in the presence of LiCl in the presence of LiA1 or NaBH4. Catalytic hydrogenation can also be used. Catalytic nitridation can be carried out using hydrogen gas in the presence of a suitable catalyst for catalytic nitrogenation, examples of which include recording, recording and turning. Suitably, the catalyst is present on an inert surface such as charcoal. The final step involves the conversion of the intermediate of formula (6a) to the compound of formula (7.1) by a cyclization reaction. This cyclization reaction occurs via an intramolecular acetalization exchange reaction. The hydrazine reaction is preferably carried out by treating the intermediate of the formula (6a) with a catalytic amount of a strong acid. In a preferred embodiment, the strong acid is selected from the group consisting of hydrochloric acid and sulfuric acid. In a specific embodiment, the cyclic action is carried out at a low temperature. The temperature is preferably less than 15 ° C, more preferably less than 5. (: After acid treatment, use appropriate test to neutralize the mixture and separate the compound 7. ^ 15 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed according to the above reaction sequence, the above method is applicable to the preparation formula (7 2) (3R, 3aR, 6aS) hexahydro-bromo-[2,3-b]nonan-3-ol.

HQ 00 7.2 縮合步驟與硝基甲烷添加步驟之反應條件係經控制,以 致使式(3b)中間物係以最高可能之產率獲得,其方式是改 變例如所俵用鹼之類型,溶劑及反應溫度。Nef反應後, 下一步驟包括使式(4,a)或(5*a)中間物分離’然後使該中間 -30 本纸張尺度適用中國國家標準(CNS)A4規格(2丨〇 X 297公爱) 1323260 A7 B7 五、發明說明(29) 物還原,以獲得式(6b)中間物HQ 00 7.2 The reaction conditions of the condensation step and the nitromethane addition step are controlled such that the intermediate of formula (3b) is obtained in the highest possible yield by, for example, changing the type of base used, solvent and reaction. temperature. After the Nef reaction, the next step involves separating the intermediate of formula (4, a) or (5*a)' and then applying the intermediate -30 paper scale to the Chinese National Standard (CNS) A4 specification (2丨〇X 297 Public love) 1323260 A7 B7 V. Description of invention (29) Reduction of matter to obtain intermediate of formula (6b)

進一步使其環化成式(7.2)化合物。 同樣地,式(7.3)之(3S,3aR,6aS)六氫-呋喃并[2,3-b]呋喃-3-醇 ,可藉由根據本發明之方法,自式(lb)之光學上純中間物 開始而獲得。 10It is further cyclized to a compound of the formula (7.2). Similarly, (3S, 3aR, 6aS) hexahydro-furo[2,3-b]furan-3-ol of formula (7.3) can be optically derived from formula (lb) by the method according to the invention Pure intermediates are obtained. 10

經濟部智慧財產局員工消費合作社印製 在第一個步驟中,係使式(lb)中間物與適當氧基羰基亞 15 甲基試劑反應,而造成式(2b)之α,/5-不飽和酯,其中P1、 Ρ2、R1及R2均具有與上文所定義者相同之意義。 OP2 R2In the first step, the Intellectual Property Office of the Intellectual Property Office of the Ministry of Economic Affairs, in the first step, reacts the intermediate of formula (lb) with the appropriate oxycarbonyl pentylene reagent to cause α, /5- of formula (2b). A saturated ester wherein P1, Ρ2, R1 and R2 have the same meanings as defined above. OP2 R2

2b 〇 反應條件係與前文關於縮合步驟所述者相同。 在第二個步驟中,係使該式(2b)酯與硝基曱烷,於適當 鹼存在下反應,而造成式(3c)與(3d)中間物,其中R1、R2 、P1及P2係如上文定義。 -31 - 本紙張尺度適用中國國家標準(CNS)A4規格(2丨0 X 297公芨) 1323260 A7 B7 五、發明說明(30)2b 〇 The reaction conditions are the same as those described above for the condensation step. In the second step, the ester of formula (2b) is reacted with nitrodecane in the presence of a suitable base to form an intermediate of formula (3c) and (3d) wherein R1, R2, P1 and P2 are As defined above. -31 - This paper size is applicable to China National Standard (CNS) A4 specification (2丨0 X 297 mm) 1323260 A7 B7 V. Description of invention (30)

3c ' 、N〇23c ', N〇2

COORCOOR

反應條仵係與前文關於硝基甲烷添加步驟所述者相同, 此反應較佳係在醇性溶劑中,於非親核性鹼譬如DBU存4 下’在室溫下進行The reaction strips are the same as those described above for the nitromethane addition step. The reaction is preferably carried out in an alcoholic solvent in a non-nucleophilic base such as DBU 4 at room temperature.

步驟包括經由Nef反應,使式(3c)與(如)中間物轉: 成其相應之曱醯基衍生物。根據較佳具體實施例,係將 (3〇與(3d)中間物以鹼處理,接著添加至濃強酸醇性溶| 中。此酸處理亦會催化保護基P1與P2之分裂,而造成 内縮醛形成,個別導致式(扑)與(4,b)中間物,其刀 及R4係如上文定義。 R I 15The step comprises translating the intermediate of formula (3c) with, for example, a N-based derivative via the Nef reaction. According to a preferred embodiment, the intermediates of (3〇 and (3d) are treated with a base, followed by addition to a strong acid alcohol solution. This acid treatment also catalyzes the splitting of the protecting groups P1 and P2, resulting in internal Acetal formation, individually leading to the intermediates of (F) and (4, b), the knives and R4 are as defined above. RI 15

經濟部智慧財產局員工消費合作社印製 20 反應條件係與前文關於Nef反應所述者相同。 在合成程序之此階段中,當R2為COOR3時,係. 與(4’b)中間物施行脫羧步驟。此脫鲮步驟包括移> (4 與(4,b)中間*内之。在一較佳具體實 脫羧步驟係經由以適當鹼,譬如氫氧化鈉或 理式(4b)與(4,b)中間物,在加熱條件下進行’於酸^作 32- 本纸張尺度適用中国®家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(31 後,個別造成式(5b)與(5*b)之脫羧基化產物。同時,式(4’b) 中間物中之R1係被氫置換,而造成中間物(5’b)中之羧酸部 份基團。Printed by the Intellectual Property Office of the Ministry of Economic Affairs, the Consumer Cooperatives. 20 The reaction conditions are the same as those described in the previous Nef response. In this stage of the synthesis procedure, when R2 is COOR3, the decarboxylation step is carried out with the (4'b) intermediate. This dislocation step includes shifting > (4 and (4, b) in the middle*. In a preferred embodiment, the decarboxylation step is via a suitable base such as sodium hydroxide or the formula (4b) and (4, b). ) Intermediates, under heating conditions, 'According to acid' 32 - This paper scale applies to China® Standard (CNS) A4 size (210 X 297 mm) 1323260 A7 B7 V. Invention description (31 after, individually caused a decarboxylation product of formula (5b) and (5*b). Meanwhile, R1 in the intermediate of formula (4'b) is replaced by hydrogen, resulting in a carboxylic acid moiety in the intermediate (5'b). group.

經濟部智慧財產局員工消費合作社印製 在下一步驟中,係將式(4’b)中間物,其中R2為氫原子, 或式(5’b)中間物,利用層析或酸/鹼萃取,與式(4b)或(5b) 中間物分離。反應係進一步以式(4’b)或(5’b)中間物進行。 在下一步驟中,係以適當還原劑,使式(4’b)或(5’b)中間 物還原,而造成式(6c)中間物,其中R4具有如上文所定義 之相同意義。 15 還原步驟可使用如前文關於還原步驟所述之相同反應條 件達成。 最後步驟包括藉由環化反應,使式(6c)中間物轉化成式 (7.3)化合物。此環化反應係經由分子内縮醛化交換反應發 生。該反應較佳係經由以催化量之強酸處理式(6c)中間物 ,在水中進行。在一較佳具體實施例中,強酸係選自包括 -33- 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(32) 鹽酸與硫酸 式(7.4)之(3S,3aS,6aR)六氫-呋喃并[2,3_b]呋喃_3_醇之製備 可適當地 7.4 藉由按照上文關於合成式(7.3)化合物所述之反應順序,及 控制縮合步驟與硝基甲烷添加步驟之條件進行,以致使式 (3b)中間物以主要異構物獲得,其方式是改變例如所使用 鹼之類型,溶劑及反應溫度。於Nef反應後,下一步驟包 括分離式(北)或(5b)中間物,然後使該中-間物還原,以獲 得式(6d)中間物,Printed by the Intellectual Property Office of the Ministry of Economic Affairs in the next step, the intermediate (4'b), where R2 is a hydrogen atom, or an intermediate of the formula (5'b), extracted by chromatography or acid/base , separated from the intermediate of formula (4b) or (5b). The reaction system is further carried out with an intermediate of the formula (4'b) or (5'b). In the next step, the intermediate of formula (4'b) or (5'b) is reduced with a suitable reducing agent to give an intermediate of formula (6c) wherein R4 has the same meaning as defined above. 15 The reduction step can be achieved using the same reaction conditions as described above for the reduction step. The final step involves the conversion of the intermediate of formula (6c) to the compound of formula (7.3) by a cyclization reaction. This cyclization reaction occurs via an intramolecular acetalization exchange reaction. The reaction is preferably carried out in water by treating the intermediate of formula (6c) with a catalytic amount of a strong acid. In a preferred embodiment, the strong acid is selected from the group consisting of -33-. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210x297 mm). 1323260 A7 B7 5. Invention Description (32) Hydrochloric acid and sulfuric acid type (7.4) (3S, 3aS, 6aR) hexahydro-furo[2,3_b]furan-3-ol can be suitably prepared by 7.4 according to the reaction sequence described above for the synthesis of the compound of formula (7.3), and The condensation step is carried out under the conditions of the nitromethane addition step such that the intermediate of the formula (3b) is obtained as the main isomer by changing, for example, the type of base used, the solvent and the reaction temperature. After the Nef reaction, the next step includes separating the (North) or (5b) intermediate, and then reducing the intermediate-intermediate to obtain the intermediate of the formula (6d).

6d 15 使其進一步環化成式(7.4)化合物。 經濟部智慧財產局員工消費合作社印製 本發明之另一方面係關於新穎中間物,及其製造方法。 本發明係關於具有式(3)之新穎中間物,其中pi與尹2係如 上文定義’ R2為COOR3,且R1與R3係如上文定義,該中間 物具有式(3.1)。 -34- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) 1323260 A7 B7 五、發明說明(336d 15 is further cyclized to the compound of formula (7.4). Printed by the Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperatives Another aspect of the present invention relates to novel intermediates, and methods of making the same. The present invention relates to a novel intermediate having the formula (3) wherein pi and y 2 are as defined above, 'R2 is COOR3, and R1 and R3 are as defined above, and the intermediate has the formula (3.1). -34- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 public) 1323260 A7 B7 V. Invention description (33

該式(3.1)中間物可藉由本發明之方法獲得。 式-(3)中間物,其中R2為氫,該中間物具有式(3.2),亦被 視為新穎的,其條件是當P1與P2—起採用而形成亞異丙基 時,R1不為甲基或乙基。The intermediate of the formula (3.1) can be obtained by the method of the present invention. An intermediate of the formula -(3) wherein R2 is hydrogen, the intermediate having the formula (3.2), is also considered novel, provided that when P1 and P2 are used together to form an isopropylidene group, R1 is not Methyl or ethyl.

COOR N〇2COOR N〇2

OP2 R2 經濟部智慧財產局員工消費合作社印製 OP2 R2 COOR1OP2 R2 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed OP2 R2 COOR1

COOR1 3d N〇2 根據較佳具體實施例,本發明係關於具有立體化學(3a) 15 、(3b)、(3c)及(3d> 之中間物,其中 P1、P2、R1、R2、R3 均 具有如上文定義之相同意義。 3c N〇2 根據更佳具體實施例,本發明係關於式(3a)、(3b)、(3c) 及(3d)中間物,其中P1、P2係一起形成毗二醇保護基,R2 為COOR3,該中間物個別具有式(3a.l)、(3b.l)、(3c.l)及(3d.l) 。適當地,R1與R3係各獨立選自包括曱基、乙基、丙基 -35 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(34: 丁基、第三-丁基及 、異丙基、正-丁基、異丁基、第 戊基,更有利的是R1與R3為相同。 ίΟ 2 C00R3 〇COOR1 3d N〇2 According to a preferred embodiment, the invention relates to an intermediate having stereochemistry (3a) 15 , (3b), (3c) and (3d), wherein P1, P2, R1, R2, R3 are Has the same meaning as defined above. 3c N〇2 According to a more preferred embodiment, the invention relates to intermediates of the formulae (3a), (3b), (3c) and (3d), wherein the P1 and P2 systems together form a a diol protecting group, R2 is COOR3, and the intermediate has the formulae (3a.l), (3b.l), (3c.l) and (3d.l) individually. Suitably, the R1 and R3 systems are each independently selected from the group consisting of Including thiol, ethyl, propyl-35 This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm) 1323260 A7 B7 V. Description of invention (34: butyl, tert-butyl, and Propyl, n-butyl, isobutyl, pentyl, more advantageously R1 and R3 are the same. ίΟ 2 C00R3 〇

C00R' 3a.l I P2 COOR3C00R' 3a.l I P2 COOR3

COOR1 3b.lCOOR1 3b.l

OOR COOR 3OOR COOR 3

3d.l 於又更佳具體實施例中,本發明係關於具有式(3a.i_)-、(3b.l) 、(3c.l)及(3d.l)之中間物,其中p1與p2 —起採用而形成二 烷基亞曱基,該中間物個別具有式(3a.la)、(3b.la)、(3c.la) 及(3d.la)〆適當地,R1與R3各獨立選自包括甲基、乙基、 丙基、異丙基、正-丁基、異丁基 '第二-丁基、第三-丁 基及戊基,更有利的是R1與R3為相同Z在一項更佳具體 實施例中,R1與R3各獨立為甲基、乙基或第三-丁基,而 更有利的是R1與R3為相同。 15 烷基 坑基 烷基 烷基3d. l In still further preferred embodiments, the invention relates to intermediates having the formulae (3a.i_)-, (3b.l), (3c.l) and (3d.l), wherein p1 and p2 Forming a dialkyl fluorenylene group, the intermediate having the formula (3a.la), (3b.la), (3c.la) and (3d.la) 〆 suitably, R1 and R3 are each independently Selected from the group consisting of methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl 'second-butyl, tert-butyl and pentyl, more advantageously R1 and R3 are the same Z In a more preferred embodiment, R1 and R3 are each independently methyl, ethyl or tert-butyl, and more advantageously R1 and R3 are the same. 15 alkyl pit alkyl alkyl

3a.la 經濟部智慧財產局員工消費合作杜印製 本發明之另一項較佳具體實施例,係關於式(3#、(3b) 、(3c)及(3d)中間物,其中P1、P2 —起形成毗二醇保護基 ,R2為Η,該中間物個別具有式(3a.2)、(3b.2)、(3c.2)及(3d.2) 。適當地,R1係選自包括曱基、乙基、丙基、異丙基、正 -丁基、異丁基 '第二-丁基、第三-丁基及戊基。 -36- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(35: 3a.2 "COOR N〇23a.la Ministry of Economic Affairs Intellectual Property Office Staff Consumption Cooperation Du printed Another preferred embodiment of the present invention relates to the intermediates of formulas (3#, (3b), (3c) and (3d), wherein P1 P2 forms a diol-protecting group, and R2 is Η. The intermediate has the formulas (3a.2), (3b.2), (3c.2) and (3d.2). Suitably, the R1 system is selected. Including thiol, ethyl, propyl, isopropyl, n-butyl, isobutyl 'second-butyl, tert-butyl and pentyl. -36- This paper scale applies to Chinese national standards ( CNS) A4 specification (210 X 297 mm) 1323260 A7 B7 V. Description of invention (35: 3a.2 "COOR N〇2

於又另一項較佳具體實施例中,本發明係關於具有式 (3a.2)、(3b.2)、(3c.2)及(3d.2)之中間物,其中 P1 與P2 —起採 用而形成二烷基亞甲基,該中間物個別具有式(3a.2a)、(3b.2a) 、(3c.2a)及(3d.2a)。適當地,R1係選自包括甲基' 乙基、 丙基、異丙基、正-丁基、異丁基、第二-丁基、第三-丁 基及戊基,更有利的是R1為曱基、乙基或第三-丁基。 烷基 烷基 15In still another preferred embodiment, the invention relates to an intermediate having the formulae (3a.2), (3b.2), (3c.2), and (3d.2), wherein P1 and P2 are It is used to form a dialkylmethylene group which has the formulae (3a.2a), (3b.2a), (3c.2a) and (3d.2a). Suitably, R1 is selected from the group consisting of methyl 'ethyl, propyl, isopropyl, n-butyl, isobutyl, second-butyl, tert-butyl and pentyl, more advantageously R1 It is a mercapto group, an ethyl group or a tri-butyl group. Alkylalkyl 15

COOR1 炫基 烷基COOR1 炫 alkyl

COOR1 3b.2a 坑基COOR1 3b.2a pit base

COOR1 3c.2a \ N〇2 坑基 技•基COOR1 3c.2a \ N〇2 pit base technology base

COOR1 3d.2a 經濟部智慧財產局員工消費合作社印製 式(3c.2a)與(3d.2a)中間物,其中R1為乙基,已被描述於 Patrocinio 等人,合成(1994), 5, 474-6 中。 適當地,在式(3a.la)、(3b.la)、(3c,la)及(3d.la)中間物, 以及(3a.2a)、(3b.2a)、(3c.2a)及(3d.2a)中,烷基係為 Cu 烷 基,較佳為^.4烷基,且最佳為曱基或乙基。 一般而言,式(3a)、(3b)、(3c)或(3d)立體異構物形式之 合成,可個別經由以式(la)或(lb)之光學上純中間物開始 進行。 -37- 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(36) 本發明之又另一方面,係關於式(4)、(4,)、⑸及(5f)中 間物,咸認其係為新穎的。該中間物可藉由根據本發明之 方法獲得。 根據敉佳具體實施例,本發明係關於式(Sa)、(5,b)中間 5物,其中R4係選自包括曱基、乙基、丙基、異丙某、正_ 丁基、異丁基、第二-丁基、第三_ 丁基及戊基'。在1一項更 -佳具體實施例中,R4為曱基或乙基。 式(5a)奶,b)中間物之合成,可合宜地個μ經由以式⑽ 或(lb)之光學上純中間物開始進行。 10 已發現式⑺化合物在藥劑製備上之特殊用途。根據較 佳具體實施例’本發明之式⑺化合物係作為先質,用於 製備抗病毒藥物’特別是抗-HIV藥物,1特別是hiv蛋白 酶抑制劑。 會導致該立體異構上純化合物形成之式(71)化合物及所 15有中間物,在製備HIV蛋白酶抑制劑上,係特別令人感興 趣,該抑制劑如在 W0 95/24385、WO 99/65870、WOOO/47551 、WO 00/76961 與 US 6,127,372、WO 01/25240、EP 0 715 618 及 經濟部智慧財產局員工消費合作社印製 W0 99/674H中所揭示者,全部均併於本文供參考,且特別 是下列HIV-蛋白酶抑制劑。 20 [(1 S,2R)_2-羥基_3-[[(4·曱氧苯基)磺醯基](2-甲基丙墓*)胺基]- ι-(苯基-甲基)丙基]-胺甲基酸(3R3aS,6aR)六氫呋喃并[2,3b] 咬喃_3-基醋(HIV蛋白酶抑制劑1);, [(lS,2R)-3-[[(4_胺基笨基)磺醯基](2甲基丙基)胺基]_2羥基_ ι-(苯基-曱基)丙基]-胺甲基酸(3R,3aS加六氫呋喃并 -38- 本纸張尺度適用中國固家χ 297公^ 丄⑷260 A7 __B? 五、發明說明(汾) 夫。南·3_基醋(HIV蛋白酶抑制劑2); [(1 S,2R)-3-[( 1,3-苯并二氧伍圜烯:基磺醯基)(2甲基丙基) 胺基]_2-羥基-1_(苯基甲基)丙基]-胺曱基酸(3R3aS,6aR)六氫 j喃并[2,3-b]呋喃-3-基酯(HIV蛋白酶抑制劑3),或其任何 5藥學上可接受之加成鹽。 因此,本發明亦關於HIV蛋白酶抑制劑丨、2、3,或其 任何藥學上可接受之鹽或前體藥物,在該HIV蛋白酶抑制 劑之化學合成中,利用根據本發明製成之式(71)化合物獲 得此種化學合成係揭示於此項技藝中,例如在w〇〇丨/2524〇 , 10 ' EP 〇 715 618 及 WO 99/67417 中。 下述實例係意欲成為本發明之說明例。提出此等實例係 為舉例說明本發明,並非欲被解釋為限制本發明之範圍。 复·驗段落 :=!_般程序: 經濟部智慧財產局員工消費合作社印製 貝子 NMR 光 s醬係被 §己錄於 Bmker Avance DPX 400 MHz NMR 波譜儀上。質子化學位移係以相對於内部四曱基矽烷(1^3, δ 0.0)之ppm ( 5)報告。分析薄層層析法(TLC)係使用矽膠 6OAF254預先塗覆板(〇·25毫米厚度)進行。報告出TLcRf 值。顯像係經由以KMn〇4在丙酮中之溶液或以香草醛在水 與濃硫酸之1/1混合物中之溶液染色而達成。分析-氣相層 析法(GC)係使用DB-XLB管柱進行。分析對掌性gc係使^ cyclodex-沒管柱進行。於兩種管柱上之偵測,係經由採用 火焰離子化偵測H達成。所有溶劑與試劑均取自市售供應 商,且使用之,而未在其使用之前進行任何處理或純化: -39· 本纸張尺度適用中國S家標準(CNS)A4規格(210x297 --------- 1323260 A7 B7 五、發明說明(38) L-5,6-0-亞異丙基古洛糖酸基_14_内酯,係根據C. Hubschwerlen 合成 I986, 962·964,製自 L_ 抗壞血酸。COOR1 3d.2a Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperatives Printed intermediates (3c.2a) and (3d.2a), where R1 is ethyl, has been described in Patrocinio et al., Synthesis (1994), 5, In 474-6. Suitably, in the formula (3a.la), (3b.la), (3c,la) and (3d.la) intermediates, and (3a.2a), (3b.2a), (3c.2a) and In (3d.2a), the alkyl group is a Cu alkyl group, preferably a ^4 alkyl group, and most preferably a mercapto group or an ethyl group. In general, the synthesis of the stereoisomers of formula (3a), (3b), (3c) or (3d) can be carried out individually via an optically pure intermediate of formula (la) or (lb). -37- This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm) 1323260 A7 B7 V. Inventive Note (36) Another aspect of the present invention relates to formula (4), (4,), (5) and (5f) intermediates, which are considered novel. This intermediate can be obtained by the method according to the invention. According to a preferred embodiment, the present invention relates to the intermediate 5 of the formula (Sa), (5, b), wherein R4 is selected from the group consisting of decyl, ethyl, propyl, isopropyl, n-butyl, and iso Butyl, second-butyl, tert-butyl and pentyl'. In a more preferred embodiment, R4 is a decyl or ethyl group. The synthesis of formula (5a) milk, b) intermediates, may conveniently be carried out via an optically pure intermediate of formula (10) or (lb). 10 The special use of the compound of formula (7) in the preparation of the medicament has been found. According to a preferred embodiment, the compound of the formula (7) of the present invention is used as a precursor for the preparation of an antiviral drug, particularly an anti-HIV drug, 1 especially a hiv protease inhibitor. Compounds of formula (71) and intermediates which result in the formation of such stereoisomerically pure compounds are of particular interest in the preparation of HIV protease inhibitors such as at WO 95/24385, WO 99. /65870, WOOO/47551, WO 00/76961 and US 6,127,372, WO 01/25240, EP 0 715 618 and the Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperatives published in W0 99/674H, all of which are For reference, and in particular the following HIV-protease inhibitors. 20 [(1 S,2R)_2-hydroxy_3-[[(4·曱-oxyphenyl)sulfonyl](2-methylpropanthene*)amino]- ι-(phenyl-methyl) Propyl]-amine methyl acid (3R3aS, 6aR) hexahydrofuran [2,3b] gnach _3- ketone (HIV protease inhibitor 1);, [(lS, 2R)-3-[[( 4_Amino-phenyl)sulfonyl](2methylpropyl)amino]_2hydroxy- ι-(phenyl-indolyl)propyl]-amine methyl acid (3R, 3aS plus hexahydrofuran -38- The paper size is applicable to China's χ χ 297 297 297 297 297 297 297 297 297 297 297 297 297 4 4 4 4 4 4 4 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 -3-[(1,3-benzodioxanthene: sulfamoyl)(2methylpropyl)amino]_2-hydroxy-1_(phenylmethyl)propyl]-amine fluorenyl Acid (3R3aS, 6aR) hexahydroj-[2,3-b]furan-3-yl ester (HIV protease inhibitor 3), or any of its 5 pharmaceutically acceptable addition salts. Thus, the present invention also With regard to the HIV protease inhibitor oxime, 2, 3, or any pharmaceutically acceptable salt or prodrug thereof, in the chemical synthesis of the HIV protease inhibitor, this is obtained using a compound of formula (71) made in accordance with the present invention. a chemical synthesis system revealed in this technique For example, the following examples are intended to be illustrative of the invention, and are intended to be illustrative of the invention, and are not intended to be construed. To limit the scope of the invention. Re-examination paragraph: =! _ General procedure: Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed Beizi NMR light s sauce system was recorded on the Bmker Avance DPX 400 MHz NMR spectrometer. Proton The chemical shift is reported in ppm relative to the internal tetradecyl decane (1^3, δ 0.0) (5). Analytical thin layer chromatography (TLC) is pre-coated with silica gel 6OAF254 (〇·25 mm thickness) The TLcRf value is reported. The imaging is achieved by dyeing a solution of KMn〇4 in acetone or a solution of vanillin in a 1/1 mixture of water and concentrated sulfuric acid. Analysis-Gas Chromatography (GC) The system was performed using a DB-XLB column. The analysis was performed on the palm-shaped gc system by the cyclodex-no-column column. The detection on the two columns was achieved by detecting the H by flame ionization. All solvents and reagents. All are taken from commercial suppliers and used, but not before they are used. Any treatment or purification: -39· This paper scale applies to China S Standard (CNS) A4 specification (210x297 --------- 1323260 A7 B7 V. Invention Description (38) L-5,6-0 - isopropylidene gulonic acid _14_ lactone, according to C. Hubschwerlen synthesis I986, 962.964, from L_ascorbic acid.

實例IExample I

經濟部智慧財產局員工消費合作社印製 1.3之合成 - 將過碘酸钾(0.25莫耳,57.5克)與碳酸氫鉀(〇25莫耳,25 克)在水(100笔升)中配成漿液’並冷卻至。使L-5 6_〇_ 15亞異丙基-古洛糖酸基-I,4-内酯(Ι·1,0.12莫耳,26克)溶於 四氫呋喃(100毫升)與水(100毫升)中,並於2〇分鐘内,逐 滴添加至(TC下之過碘酸鹽溶液中。於添加後,將混合物 於室溫下攪拌4小時,然後冷卻至(TC。藉過濾移除固體, 並以四氫呋喃(100毫升)洗滌。將含有2,3_〇_亞異丙基丙二 20羥醛(L2)之合併有機濾液,在未蒸發溶劑下,使角^下一 步驟中。將膦酸基醋酸三乙酯(0.114莫耳,32克)添加至〇 °(:下之合併濾液中。使碳酸鉀(0.6莫耳,幻克)溶^水〇6〇 毫升)中,並在0°C下,於1小時内,逐滴添加至反應混合 物中。將此兩相溶液攪拌4小時。分離有機相,並將水相 -40- 本纸張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(39) "~~ 以醋酸乙酯萃取(3 X 1〇〇毫升)。將合併之有機相以水洗務 (2x100毫升)’並蒸發溶劑,獲得淡黃色油。使此粗製油 經過矽膠過濾,以正-己烷/醋酸乙酯(1〇/9〇)溶離,產生 化合物(I.3 ’ I4·3克,產率=^0%),為E/z混合物,其比例 5為%/4(藉由1HNMR測得)。lHNMR光譜係與所要之結構 一致。Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, Printing 1.3 Synthesis - Potassium periodate (0.25 m, 57.5 g) and potassium bicarbonate (〇25 mol, 25 g) in water (100 liters) The slurry 'cools and cools to. L-5 6_〇_ 15 isopropylidene-gulonic acid-I,4-lactone (Ι·1, 0.12 mol, 26 g) was dissolved in tetrahydrofuran (100 ml) and water (100 ml) And, within 2 minutes, added dropwise to the periodate solution (TC). After the addition, the mixture was stirred at room temperature for 4 hours and then cooled to (TC. Remove solids by filtration And washed with tetrahydrofuran (100 ml). The combined organic filtrate containing 2,3_〇_isopropylidenepropane di 20 aldehyde (L2) was used in the next step without evaporation of the solvent. Triethyl phosphonate acetate (0.114 mol, 32 g) was added to the combined filtrate of 〇° (: potassium carbonate (0.6 m, gram) dissolved in water) (6 ml) Add to the reaction mixture dropwise at 0 ° C for 1 hour. Stir the two-phase solution for 4 hours. Separate the organic phase, and apply the water phase - 40 - this paper size to the Chinese National Standard (CNS) A4 Specification (210 X 297 mm) 1323260 A7 B7 V. Inventive Note (39) "~~ Extract with ethyl acetate (3 X 1 〇〇ml). Combine the organic phase with water (2x100 ml) The solvent was evaporated to give a pale-yellow oil. The crude oil was filtered over silica gel eluting with n-hexane/ethyl acetate (1 〇/9 〇) to give compound (I.3 ' I4·3 g, yield = ^0%), which is an E/z mixture, the ratio 5 is %/4 (measured by 1H NMR). The lH NMR spectrum is consistent with the desired structure.

Li之合成 使化合物(I.3,〇·1莫耳,2〇克,E/z : 96/4)與硝基曱烷(〇 u 莫耳’ 6.7克)溶於乙腈(2〇〇毫升)中,並冷卻至〇。〇。於5 10分鐘内逐滴添加I,8-二氮雙環并-[no]十一烯(〇·ΐ5莫耳, 22.8克)在乙腈(50毫升)中之溶液。將反應混合物於室溫下 攪拌過夜。然後,於減壓下移除大部份溶劑《將此油狀殘 留物以水(200毫升)稀釋,並以醋酸乙酯萃取(3x200毫升) 。將合併之有機層以5%鹽酸(2〇〇毫升),然後以飽和碳酸 15氫納溶液洗滌。以MgS04脫水乾燥,並於減壓下蒸發,獲 得中間物(I.4 ’ 9克’產率=34%),其同側/對側比例為75/25 (藉由iHNMR測得)。iHNMR光譜係與所要之結構一致。 1.5之合成 經濟部智慧財產局員工消費合作社印製 使化合物(I·4,〇.〇3莫耳,7·8克,同側/對側:〜25)在 20 四氫呋喃(1〇〇毫升)中之溶液冷卻至〇。(:。於30分鐘内,分 次添加硼氫化鋰(〇.〇45莫耳,!克),並將混合物於室溫下 攪拌過夜。於冷卻(〇。〇下,藉由慢慢添加飽和氣化銨溶 液(100毫升),使反應淬滅,以醋酸乙酯萃取(10x50毫升) ,並以MgS04脫水乾燥。在減壓下蒸發,獲得化合物(1.5 -41 - 本纸張尺度適用中固國家標準(CNS)A4規格(21〇 X 297公釐) ' 1323260 A7 B7 五、發明說明(40) ' " " ’ 6.〇2克,產率=92%),為油狀物。1HNMR光譜係與所 要之結構一致。 古氧』夫喃生jg,3-bl呋喃_3_醇與7.2、之合成: 於化合物(I.5,0·011莫耳,24克,同側/對侧混合物) 5 在異丙醇(20毫升)中之經搜拌溶液内’在30分鐘内,於室 溫下分次添加第三-丁醇卸(〇〇132莫耳’ I.5克)^將驗性 溶液轉移至添液漏斗,並於1〇分鐘内逐滴添加至濃(37%) 鹽酸(0.0275莫耳,2.3毫升)在異丙醇(20毫升)中之經冷卻(〇 °C)激烈攪拌混合物内。將反應混合物在室溫下攪拌2小 10時’然後遂滴添加三乙胺(0.022莫耳,2.2克)’造成Et3N.HCl 鹽沉澱。將反應混合物以醋酸乙酯(50毫升)稀釋’並過濾 以移除鹽。在減壓下蒸發溶劑。將殘留物以醋酸乙酯(5〇 毫升)稀釋,造成更多Et3 N.HC1鹽沉澱。藉過濾移除此鹽 ,並在減壓下蒸發溶劑。將殘留油藉矽膠填充柱過濾,進 15 一步純化,使用醋酸乙酯作為溶離劑,而得化合物之混合 物(7.1/7.2,1.03克,產率=72% ),其比例為78/22 (藉由 1 H NMR測得)。純化合物之分析試樣(u,1 = 〇 2乃與(π 經濟部智慧財產局員工消費合作社印製 ’ Rf7.2=0.15)係利用矽膠層析獲得,使用醋酸乙酷作為溶 劑。 20 (3R,3aS,6aR)-六氫-吱喃并[2,3-b]吱喃-3-醇(71) : 〇 MHz,CDC13) 5 1.80-1.91 (1H,m),2.28-2.34 (1H,叫,2 83 2 89 (出, m),3.11 (1H,寬廣 s),3.35-3.59 (lH,m),3.85-3.98 (3H m) 4 38 4 45 (1H, m), 5.66. (1H, d, J = 5.2 Hz). (311>尺,祕)-六氫-嗅读并[2,3-13]吱味_3_醇(7.2):1^·^ -42- 本纸張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(41 (400 MHz, CDCI3) δ 1.68-1.75 (lH,m), 2.12-2.23 (lH,m), 2.42 (1Η> 寬廣 s)’ 2.79-2.85 (1H,m),3.81-3.91 (3H, m), 3.96-4.01 (iH, m), 4.23 (lH,m), 5.89 (1H, d,J = 4.9 Hz).The synthesis of Li makes the compound (I.3, 〇·1 mol, 2 gram, E/z: 96/4) and nitro decane (〇u Moer '6.7 g) dissolved in acetonitrile (2 〇〇 ml) ) and cool to 〇. Hey. A solution of I,8-diazabicyclo-[no]undecene (〇·ΐ5 mol, 22.8 g) in acetonitrile (50 mL) was added dropwise over 5 10 min. The reaction mixture was stirred at room temperature overnight. Then, most of the solvent was removed under reduced pressure. The residue was diluted with water (200 mL) and ethyl acetate (3. The combined organic layers were washed with 5% aqueous HCl (2 mL) and then brine. Drying with MgS04 and evaporation under reduced pressure afforded intermediate (I.4''9"yield" The iH NMR spectrum is consistent with the desired structure. 1.5 Synthetic Economics Department Intellectual Property Bureau employee consumption cooperative printed compound (I·4, 〇.〇3 Mo, 7.8 g, ipsilateral/contralateral: ~25) in 20 tetrahydrofuran (1 〇〇 ml) The solution in the solution was cooled to 〇. (:. Add lithium borohydride (〇.〇45 mol, !g) in portions over 30 minutes, and stir the mixture at room temperature overnight. After cooling (〇.〇, by slowly adding saturation The solution was quenched with ammonium sulfate (100 ml), and then quenched with ethyl acetate (10×50 ml) and dried with EtOAc EtOAc EtOAc. National Standard (CNS) A4 Specification (21〇X 297 mm) ' 1323260 A7 B7 V. Description of Invention (40) ' "" ' 6. 2 g, yield = 92%), oily. The 1H NMR spectrum is consistent with the desired structure. The synthesis of the ancient oxygen suffolk jg, 3-bl furan _3-alcohol and 7.2, the compound: I.5, 0·011 mol, 24 g, ipsilateral / The contralateral mixture) 5 In a solution of isopropyl alcohol (20 ml), the third-butanol unloading (〇〇132mer' I.5g was added in portions at room temperature within 30 minutes. Transfer the test solution to the addition funnel and add dropwise to the concentrated (37%) hydrochloric acid (0.0275 mol, 2.3 ml) in isopropanol (20 ml) in 1 min. °C) intensely stirred The mixture was stirred at room temperature for 2 hours and 10 hrs. Then triethylamine (0.022 mol, 2.2 g) was added dropwise to cause precipitation of Et3N.HCl salt. The reaction mixture was taken ethyl acetate (50 ml) Diluted 'and filtered to remove the salt. Evaporate the solvent under reduced pressure. The residue was diluted with ethyl acetate (5 mL) to precipitate more Et3 N.HC1 salt. The solvent was evaporated under reduced pressure. The residual oil was filtered on a silica gel-packed column, and purified in 15 steps using ethyl acetate as a solvent to give a mixture of compounds (7.1/7.2, 1.03 g, yield = 72%). It is 78/22 (measured by 1 H NMR). The analysis sample of pure compound (u, 1 = 〇2 is used with (π Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 'Rf7.2=0.15) Obtained by silica gel chromatography using ethyl acetate as a solvent. 20 (3R, 3aS, 6aR)-hexahydro-indolo[2,3-b]nonan-3-ol (71) : 〇MHz, CDC13) 5 1.80-1.91 (1H, m), 2.28-2.34 (1H, called, 2 83 2 89 (out, m), 3.11 (1H, wide s), 3.35-3.59 (lH, m), 3.85-3.98 (3H m ) 4 38 4 45 (1H, m), 5.66. (1H, d, J = 5.2 Hz). (311> ruler, secret) - hexahydro-sniffing and [2,3-13] astringency _3_ol (7.2) :1^·^ -42- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1323260 A7 B7 V. Description of invention (41 (400 MHz, CDCI3) δ 1.68-1.75 (lH, m), 2.12-2.23 (lH,m), 2.42 (1Η> broad s)' 2.79-2.85 (1H,m),3.81-3.91 (3H, m), 3.96-4.01 (iH, m), 4.23 (lH ,m), 5.89 (1H, d, J = 4.9 Hz).

實例IIExample II

V-^^COOEt 11.1V-^^COOEt 11.1

CH3NO2 KOHCH3NO2 KOH

H2S〇4 Q’、 /—C〇〇Et ^ \—( +H2S〇4 Q’, /—C〇〇Et ^ \—( +

EtOH 乂 〇E 丨 II.3 、〇Et II.3'EtOH 乂 〇E 丨 II.3 , 〇Et II.3'

HQHQ

15 經濟部智慧財產局員工消費合作社印製 1) UBH415 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1) UBH4

2) HCI2) HCI

HOHO

+ CQ 7.2 II.3與IL3’之合成 使硝基甲烧(0.011莫耳,0 67克)在乙醇(5亳升)中之溶液 冷卻至0°C。逐滴添加乙醇(5毫升)中之丨,8•二氮雙環并[5 4 〇] 十一 _7_烯(0.015莫耳,克),並將反應物攪拌3〇分鐘。 使化合物(II.1,0.01莫耳,2克,E/z = 96/句溶於乙醇(5毫 升)中’並於oc下逐滴添加至該溶液中。將反應混合物於 室溫下撲摔過夜’然後轉移至添液漏斗,並於30分鐘内 逐滴添加至濃硫酸(〇.〇3莫耳,〇8毫升)在乙醇(i〇i升)中 之經冷卻(0C)激烈攪拌溶液内。在室溫下攪拌過夜後, 將反應混合物以水⑽毫升)稀釋独二氯甲烷萃取(3 χ 5〇 毫升)將β併之有機相以飽和碳酸氫納溶液⑽毫升)洗 蘇,以_〇4脫水乾燥,及在減壓下蒸發而得產物之粗 -43-+ CQ 7.2 Synthesis of II.3 and IL3' A solution of nitro-methyl (0.011 mol, 0 67 g) in ethanol (5 liters) was cooled to 0 °C. Ethanol (5 ml) was added dropwise, 8 • diazabicyclo[5 4 〇] eleven _7-ene (0.015 mol, gram), and the reaction was stirred for 3 min. The compound (II.1, 0.01 mol, 2 g, E/z = 96/s in ethanol (5 ml) was added to the solution and added dropwise to the solution at oc. The reaction mixture was allowed to flow at room temperature. Fall overnight' then transfer to the addition funnel and add dropwise to concentrated sulfuric acid (〇.〇3mol, 〇8ml) in 30min (30°C) in ethanol (iC). After stirring at room temperature overnight, the reaction mixture was diluted with water (10 ml), extracted with dichloromethane (3 χ 5 mL), and the organic phase was washed with saturated sodium hydrogen carbonate (10 mL). Drying with _〇4, and evaporating under reduced pressure to obtain crude product-43-

1323260 A7 B7 五、發明說明(42) 製混合物(ΙΙ,ΜΙ·3,,I·27克,產率=58%),為油狀物。使 用1HNMR分析,確認化合物II.3為產物混合物中之主要成 份。將粗產物混合物以本身使用在下一步驟中。 (7.1)與(7.2)自叙劁(ΙΙ.3/ΙΙ.3’)之会成: 5 使粗產物混合物(Π.3/ΙΙ·3·) (〇.〇〇6莫耳,1 ·27克)溶於四氣 呋喃(20毫升)中,並冷卻至〇°C。於5分鐘内分次添加蝴^ 化鋰(0.0〇9莫耳,200毫克),並將混合物於室溫下授掉過 夜。在減壓下蒸發溶劑,並使殘留物溶於異丙醇(25毫升) 中。逐滴添加濃(37%)鹽酸(1毫升),並將混合物在室溫下 10 攪拌4小時。然後,逐滴添加三乙胺(5毫升),造成Et3N.HCl 鹽沉澱。將反應混合物以醋酸乙酯(100毫升)稀釋,並過 濾以移除鹽。在減壓下蒸發溶劑。將殘留物以醋酸乙酯(i 〇 〇 毫升)稀釋,造成更多Et3N.HCl鹽沉澱。藉過濾移除鹽, 並在減壓下蒸發溶劑。將殘留油藉由矽膠填充柱過濾,進 15 一步純化,使用醋酸乙酯作為溶離劑,而得化合物之混合 物(7.1/7.2,0.68克,產率87%),其比例為87/13 (藉由1 H nmr 測得)。iHNMR光譜係與所要之結構一致。 經濟部智慧財產局員工消費合作社印製 -44 - 本纸張尺度適用t國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(43)1323260 A7 B7 V. INSTRUCTIONS (42) Preparation of a mixture (ΙΙ, ΜΙ·3,, I·27 g, yield = 58%), as an oil. Using 1H NMR analysis, it was confirmed that the compound II.3 was the main component in the product mixture. The crude product mixture was used as such in the next step. (7.1) and (7.2) from the narration (ΙΙ.3/ΙΙ.3'): 5 Make the crude product mixture (Π.3/ΙΙ·3·) (〇.〇〇6莫耳,1 ·27 G) was dissolved in tetra-furan (20 mL) and cooled to 〇 ° C. Lithium oxide (0.0 〇 9 mol, 200 mg) was added in portions over 5 minutes, and the mixture was allowed to stand overnight at room temperature. The solvent was evaporated under reduced pressure. Concentrated (37%) hydrochloric acid (1 mL) was added dropwise, and the mixture was stirred at room temperature for 10 hr. Then, triethylamine (5 ml) was added dropwise to cause precipitation of Et3N.HCl salt. The reaction mixture was diluted with ethyl acetate (100 mL) and filtered and evaporated. The solvent was evaporated under reduced pressure. The residue was diluted with ethyl acetate (i.sub.1 mL) to afford a further Et3N. The salt was removed by filtration and the solvent was evaporated under reduced pressure. The residual oil was filtered through a silica gel packed column, and purified in 15 steps using ethyl acetate as a solvent to obtain a mixture of compounds (7.1/7.2, 0.68 g, yield 87%) in a ratio of 87/13. Measured by 1 H nmr). The iH NMR spectrum is consistent with the desired structure. Printed by the Intellectual Property Office of the Ministry of Economic Affairs, the Consumers' Cooperatives -44 - This paper scale applies to the National Standard (CNS) A4 specification (210x297 mm). 1323260 A7 B7 V. Description of invention (43)

實例HI °Λγη mu 〇 〈COOMe COOMeExample HI °Λγη mu 〇 <COOMe COOMe

COOMe COOMe III.2COOMe COOMe III.2

ch3no2 催化用DBUCh3no2 catalytic DBU

1) NaOMe 2) H2S04 MeOOC HQ &gt;~CO〇Me1) NaOMe 2) H2S04 MeOOC HQ &gt;~CO〇Me

〇 A HQ /~COOH -〇Me〇 A HQ /~COOH -〇Me

〇‘ 〇 III.5 、〇〇 ‘ 〇 III.5 〇

'〇Me 1) LiBH4 2) 1N HCI'〇Me 1) LiBH4 2) 1N HCI

1) KOH 2) AcOH 〇/^^CO〇Me III.51 、〇 -〇Me 111.4 〇 OMe ili.4- 經濟部智慧財產局員工消費合作社印製1) KOH 2) AcOH 〇/^^CO〇Me III.51 , 〇 -〇Me 111.4 〇 OMe ili.4- Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative

HO 〇&gt;”&quot;〇 7.1 15 III.2之合成HO 〇&gt;"&quot;〇 7.1 15 Synthesis of III.2

將2,3-0-亞異丙基-丙二羥醛(III.l,0.1莫耳,65克20% w/wIII.1在四氫呋喃中之溶液)與丙二酸二甲酯(0.15莫耳, 19.8克)、醋酸酐(0.3莫耳,30.6克)及吡啶(0.05莫耳,3_95 克)混合,並於室溫下攪拌過夜。在減壓下蒸發反應混合 20 物。將殘留油以二氣曱烷(200毫升)稀釋,以飽和碳酸氫 鈉溶液洗滌(3x100毫升),以MgS04脫水乾燥及在減壓下 蒸發。分級蒸餾獲得(III.2,沸點:88-94°C/〇.〇3毫米Hg,14.2 克,產率=58%,藉由GC之純度:83%)。TLC(醋酸乙酯 / 己烷20/80) : Rf(III.2)=0·43 (ΚΜη04 ’ 在丙酮中)。1HNMR -45 - 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(44) (400 MHz,CDC13) : δ 1.39 (3Η, s), 1.45 (3H, s), 3.71-3.75 (1H, m), 3.81 (3H, s), 3.83 (3H, s), 4.25-4.29 (1H, m), 4.90-4.95 (1H, m), 7.04 (1H, d, J = 7.1 Hz). (III.3)之合成: 5 於(III.2,2毫莫耳,490毫克)在曱醇(20毫升)中之經攪 拌溶液内,首先添加硝基甲烷(2.2毫莫耳,134毫克),然 後是1,8-二氮雙環并[5.4.0]十一-7-烯(0.5毫莫耳,76毫克),· 並將反應混合物在室溫下攪拌3小時。在減壓下蒸發溶劑 。將殘留油以飽和氯化銨溶液稀釋,以二氣曱烷萃取,以 10 MgS04脫水乾燥,及在減壓下蒸發,而得粗製(III.3),為 同側/對側混合物,其比例範圍從9(V10至97/3 (藉由 iHNMR 測得)。TLC(醋酸乙酯 / 己烷20/80) : Rf(III.3) = 0.29 (ΚΜη04,在丙酮中)··同側/對侧-(111,3)異構物並未以 分離點顯示於TLC上。化合物同側-(III.3)之結構係由粗製 15 反應混合物之1 H NMR光譜確認:同側-(III.3) : 1 H NMR (400 MHz, CDC13) : δ 1.23 (3Η,s),1.31 (3Η,s),3.13 (1Η,〜五重峰, 經濟部智慧財產局員工消費合作社印製 J = 5.5 Hz),3.55 (1H,d,J = 5.5 Hz),3.66-3.69 (重疊,111,111),3.68(311, s), 3.70 (3H, s), 4.05 (1H, dd, Jt = 8.8 Hz, J2 = 6.7 Hz), 4.22 (1H, ~q, J -5.9 Hz), 4.60 (1H, dd, = 14.8 Hz, J2= 4.8 Hz), 4.67 (1H, dd, J! = 14.8 20 Hz, J2= 5.9 Hz). (III.4/III.4,)自(III.2)之合成: 於(III.2,0.05莫耳,12.2克)在曱醇(50毫升)中之經攪拌 溶液内,首先添加硝基甲烷(0.055莫耳,3_36克),然後是1,8-二氮雙環并[5.4.0]十一-7-烯(5毫莫耳,760毫克)’並將反 -46 - 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 Α7 Β7 五、發明說明(45) 應混合物在室溫下攪拌4小時》使反應混合物冷卻至〇β(: ’ 並於30分鐘内,逐滴添加甲醇鈉别在甲醇中之溶液(〇〇5 莫耳,25毫升)^接著,將混合物轉移至添液漏斗,並於45 分鐘内,逐滴添加至濃硫酸(0.125莫耳,12克)在甲醇(25 5毫升)中之經冷卻激烈攪拌溶液内,保持内部溫度^^匚。 在添加期間,形成白色沉澱物,並將此懸浮液於室溫下攪 拌過夜。使反應混合物蒸發至原先體積之一半,然後慢慢 地倒入經冷卻之飽和碳酸氫鈉溶液(2〇〇毫升)中,保持内 部溫度&lt;10°C。將水相以醋酸乙醋萃取(4 X 50毫升),將合 10併之萃液以水(5〇毫升)洗滌’並蒸發,獲得粗製化合物之 混合物(ΙΙΙ.4/ΙΙΙ.4’ ’ 8.3&lt;7克’產率=78%),為油狀物β粗製 反應混合物之1 H NMR光譜顯示化合物(ΠΙ.4)係為主要反應 產物。化合物(ΙΙΙ.4)之分析試樣,係於矽膠上藉急驟式層 析’以醋酸乙i旨/己院50/50溶離而獲得。TLC (醋酸乙酉旨 15 / 己烧 50/50) : π. 4 广 0.45 (ΚΜη04,在丙酮中)。(UL4) :1 H NMR (400 MHz, CDC13) : δ 3.33 (3Η, s), 3.39 (1HS dd, = 7.〇 Hz, J2= 4.4 Hz), 3.58 (1H, d, J = 4.4 Hz), 3.82 (3H, s), 3.97 (1H, dd, 經濟部智慧財產局員工消費合作社印製 = 11 Hz, J2= 3.9 Hz), 4.10 (1H, d, J - 11 Hz), 4.95 (1H, s), 5.23 (1H, dd, 1^7.0 Hz, J2 = 3.9 Hz). 20 (ΠΙ.5)之合成: … 使氫氧化鉀(0.025莫耳,1·42克)溶於甲醇(10毫升)與水(2 毫升)十。添加粗製(ΙΙΙ.4/ΙΙΙ.4,,0.023莫耳,5.2克)在甲醇(10 毫升)中之溶液,並將反應混合物於回流下加熱2至3小時 。TLC分析顯示所有起始物質(ΠΙ·4/ΙΙΙ·4,)完全轉化,並使 -47- 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(46) &quot; 反應混合物在減塵下濃縮成原先體積之^。將殘留溶液 與醋酸(10毫升)混合,並於室溫下攪拌2小時。缺後,將 反應混合物以水(20毫升)稀釋,並以醋酸乙酿萃取(3χ2〇 毫升)。將合併之有機層以飽和碳醆氫鈉溶液(2〇毫升)洗 5滌,以MgS〇4脫水乾燥,及在減壓下蒸發,而得化合物(IIL5 ’ 2_35克,產率= 65%),為固體。化合物(ms)i分析試 ―樣像經由自異丙醇再結晶而獲得,提供純化合物, 為無色針狀物。TLC(Et〇Ac) _· Rf(In 5) = 〇49。(ιπ5) · 1H NMR (400 MHz,CDCl3) : 5 2.51 (1H,dd,=18 6 Hz,J2 = 4 〇 10 Hz), 2.84 (1H, dd, ίγ = 18.6 Hz, J2= 11.3 Hz), 3.00-3.06 (1H, m), 3.33 (3H, s), 3.95 (1H, dd, = 10.9 Hz, J2= 3.9 Hz), 4.10 (1H, d, J = l〇 9 Hz), 4.88 (1H, s), 5.14 (1H, dd, Jj = 7.0 Hz, J2= 3.9 Hz) (7.1)自(III.5)之合成:2,3-0-isopropylidene-propanedialdehyde (III.l, 0.1 mol, 65 g of 20% w/w III.1 in tetrahydrofuran) with dimethyl malonate (0.15 Mo The ear, 19.8 g), acetic anhydride (0.3 mol, 30.6 g) and pyridine (0.05 mol, 3_95 g) were combined and stirred at room temperature overnight. The reaction mixture was evaporated under reduced pressure. The residual oil was diluted with dioxane (200 mL), EtOAc (EtOAc) Fractional distillation gave (III.2, Boiling Point: 88-94 ° C / 〇. 〇 3 mm Hg, 14.2 g, yield = 58%, purity by GC: 83%). TLC (ethyl acetate / hexane 20/80): Rf (III.2) = 0.43 ( ΚΜ η 04 ' in acetone). 1HNMR -45 - This paper size applies to China National Standard (CNS) A4 specification (210x297 mm) 1323260 A7 B7 V. Description of invention (44) (400 MHz, CDC13): δ 1.39 (3Η, s), 1.45 (3H, s), 3.71-3.75 (1H, m), 3.81 (3H, s), 3.83 (3H, s), 4.25-4.29 (1H, m), 4.90-4.95 (1H, m), 7.04 (1H, d, J = 7.1 Hz). Synthesis of (III.3): 5 In a stirred solution of (III.2, 2 mmol, 490 mg) in methanol (20 mL), first add nitromethane (2.2 Millol, 134 mg), then 1,8-diazabicyclo[5.4.0]undec-7-ene (0.5 mmol, 76 mg), and the reaction mixture was stirred at room temperature 3 hour. The solvent was evaporated under reduced pressure. The residual oil was diluted with a saturated ammonium chloride solution, extracted with dioxane, dehydrated and dried with 10 MgS04, and evaporated under reduced pressure to give crude (III.3) as the ipsilateral/di-side mixture. The range is from 9 (V10 to 97/3 (measured by iHNMR). TLC (ethyl acetate / hexane 20/80): Rf (III.3) = 0.29 (ΚΜη04, in acetone)·· ipsilateral/ The contra-(111,3) isomer was not shown on the TLC as the separation point. The structure of the compound ipsilateral-(III.3) was confirmed by 1 H NMR spectroscopy of the crude 15 reaction mixture: ipsilateral-(III .3) : 1 H NMR (400 MHz, CDC13) : δ 1.23 (3Η, s), 1.31 (3Η, s), 3.13 (1Η, ~五重峰, Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative Printed J = 5.5 Hz), 3.55 (1H, d, J = 5.5 Hz), 3.66-3.69 (overlap, 111, 111), 3.68 (311, s), 3.70 (3H, s), 4.05 (1H, dd, Jt = 8.8 Hz, J2 = 6.7 Hz), 4.22 (1H, ~q, J -5.9 Hz), 4.60 (1H, dd, = 14.8 Hz, J2 = 4.8 Hz), 4.67 (1H, dd, J! = 14.8 20 Hz, J2= 5.9 Hz). (III.4/III.4,) Synthesis from (III.2): Stirring in (III.2, 0.05 mol, 12.2 g) in decyl alcohol (50 ml) Inside, first add nitromethane (0.055 mol, 3_36 g), then 1,8-diazabicyclo[5.4.0]undec-7-ene (5 mmol, 760 mg)' and will -46 - This paper size is applicable to China National Standard (CNS) A4 specification (210x297 mm) 1323260 Α7 Β7 5. Inventive Note (45) The mixture should be stirred at room temperature for 4 hours" to cool the reaction mixture to 〇β (: ' And add a solution of sodium methoxide in methanol (〇〇5 ml, 25 ml) dropwise over 30 minutes. Then, transfer the mixture to the addition funnel and add to the concentrate in 45 minutes. Sulfuric acid (0.125 mol, 12 g) was stirred in a vigorously stirred solution of methanol (25 5 mL) to maintain the internal temperature. During the addition, a white precipitate formed and the suspension was allowed to stand at room temperature. Stir overnight. Evaporate the reaction mixture to one and a half of the original volume, then slowly pour into a cooled saturated sodium bicarbonate solution (2 mL) maintaining the internal temperature &lt;10 ° C. Extract with vinegar (4 X 50 ml) and wash the combined solution with water (5 ml). A mixture of the crude compound was obtained (ΙΙΙ.4/ΙΙΙ.4' ' 8.3 &lt; 7 g 'yield = 78%) as a crude H. It is the main reaction product. The analysis sample of the compound (ΙΙΙ.4) was obtained by rapid-sequence chromatography on silica gel, and was obtained by dissolving acetic acid in the form of 50/50. TLC (acetate acetate 15 / hexane 50/50): π. 4 0.45 (ΚΜη04, in acetone). (UL4) : 1 H NMR (400 MHz, CDC13) : δ 3.33 (3Η, s), 3.39 (1HS dd, = 7.〇Hz, J2= 4.4 Hz), 3.58 (1H, d, J = 4.4 Hz) , 3.82 (3H, s), 3.97 (1H, dd, Ministry of Economic Affairs, Intellectual Property Office, employee consumption cooperative printing = 11 Hz, J2 = 3.9 Hz), 4.10 (1H, d, J - 11 Hz), 4.95 (1H, s), 5.23 (1H, dd, 1^7.0 Hz, J2 = 3.9 Hz). 20 (ΠΙ.5) Synthesis: ... Dissolve potassium hydroxide (0.025 mol, 1.42 g) in methanol (10 ml) ) Ten with water (2 ml). A solution of crude (ΙΙΙ.4/ΙΙΙ.4,, 0.023 mol, 5.2 g) in methanol (10 ml) was added and the reaction mixture was heated under reflux for 2 to 3 hours. TLC analysis showed that all starting materials (ΠΙ·4/ΙΙΙ·4,) were completely converted, and the -47- paper scale was applicable to the Chinese National Standard (CNS) A4 specification (210x297 mm). 1323260 A7 B7 V. Description of the invention (46) &quot; The reaction mixture is concentrated under dust reduction to the original volume. The residual solution was mixed with acetic acid (10 ml) and stirred at room temperature for 2 hr. After the absence, the reaction mixture was diluted with water (20 ml) and extracted with ethyl acetate (3 χ 2 毫升). The combined organic layers were washed with a saturated aqueous solution of sodium hydrogencarbonate (2 mL), dried over EtOAc EtOAc EtOAc EtOAc EtOAc , is a solid. Compound (ms) i analysis - The sample was obtained by recrystallization from isopropanol to provide a pure compound as a colorless needle. TLC(Et〇Ac) _· Rf(In 5) = 〇49. (ιπ5) · 1H NMR (400 MHz, CDCl3): 5 2.51 (1H, dd, =18 6 Hz, J2 = 4 〇10 Hz), 2.84 (1H, dd, ίγ = 18.6 Hz, J2 = 11.3 Hz), 3.00-3.06 (1H, m), 3.33 (3H, s), 3.95 (1H, dd, = 10.9 Hz, J2 = 3.9 Hz), 4.10 (1H, d, J = l〇9 Hz), 4.88 (1H, s), 5.14 (1H, dd, Jj = 7.0 Hz, J2 = 3.9 Hz) (7.1) Synthesis from (III.5):

經濟部智慧財產局員工消費合作社印M .於化合物(in·5 ’ 〇·〇ιι莫耳,I·88克)在四氫呋喃(20毫升) 15中之冷卻(0°c)溶液内,在10分鐘内分次添加硼氫化鋰 (0.0Π莫耳,37〇毫克)。將此懸浮液於室溫下攪拌過夜, 直到TLC分析顯示起始物質(111.5)完全轉化。然後,使反 應混合物在冰上冷卻,並藉由添加水(5毫升)使反應淬滅 。在減壓下蒸發反應混合物(浴溫=40〇c,p = 2〇〇毫巴), 20直到蒸發出大部份四氫呋喃為止,並將殘留水溶趸以2\ 鹽酸酸化至ρΗ = 0-1。將反應混合物在室溫下攪拌丨小時, 以氯化納飽和,並以醋酸乙酯萃取(5 χ 2〇毫升)。將合併 之有機層以MgS〇4脫水乾燥,及在減壓下蒸發,獲得化合 物(7.1,1.01克,產率= 71%),為無色油。(71)之結構係 -48- 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A7 B7 五、發明說明(π) 藉由1HNMR光譜確認。化合物(7.1)之對掌異構物純度, 係藉由其醋酸鹽之GC分析測定。因此,將化合物(7J,〇.5 克)與醋酸酐(2克)及N,N-二甲基冰胺基吡啶(丨〇〇毫克)混合 ’並於室溫下攪拌過夜。將反應混合物以己烷(5〇毫升)稀 5釋,並以飽和碳酸氫鹽溶液(2X50毫升),然後以水(50毫 升)洗滌。己烷溶液之對掌性〇(:分析,允許測定化合物(7.1} 之對掌異構物過量係&gt;99%。 -. — ^ 實例IV (〇OMe Q COOMe 〇 IV.1Ministry of Economic Affairs, Intellectual Property Office, Staff Cooperatives, M. In a solution of compound (in·5 ' 〇·〇ιι Mo, I·88 g) in tetrahydrofuran (20 ml) 15 in a cooled (0 ° c) solution, at 10 Lithium borohydride (0.0 Torr, 37 〇 mg) was added in portions over a minute. The suspension was stirred at room temperature overnight until TLC analysis showed complete conversion of starting material (111.5). Then, the reaction mixture was cooled on ice, and the reaction was quenched by water (5 ml). Evaporate the reaction mixture under reduced pressure (bath temperature = 40 〇c, p = 2 mbar), 20 until most of the tetrahydrofuran is evaporated, and the residual water is dissolved and acidified to pH Η = 0-1 . The reaction mixture was stirred at rt for EtOAc (EtOAc) (EtOAc) The combined organic layers were dried with EtOAc (EtOAc m.) (71) Structure -48- This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm) 1323260 A7 B7 V. Description of invention (π) Confirmed by 1H NMR spectroscopy. The purity of the palm isomer of the compound (7.1) was determined by GC analysis of its acetate. Therefore, the compound (7J, 〇. 5 g) was mixed with acetic anhydride (2 g) and N,N-dimethyl-glycolidine (methanol) and stirred at room temperature overnight. The reaction mixture was diluted with hexane (5 mL) and washed with EtOAc (EtOAc) The palmar enthalpy of the hexane solution (: analysis, allowing the determination of the compound (7.1) of the palmo isomer excess system &gt; 99%. -. - ^ Example IV (〇OMe Q COOMe 〇 IV.1

ΗΗ

ch3no2 COOMe催化用DBU COOMe IV.2Ch3no2 COOMe catalytic DBU COOMe IV.2

HQ 1) UBH4 2) 濃 HC1 又 COOMe I 产COOMe o2h IV.3 . 1) NaOMe 2) H2S04 MeOOC COOMe hq )™CO〇Me 15HQ 1) UBH4 2) Concentrated HC1 and COOMe I COOMe o2h IV.3 . 1) NaOMe 2) H2S04 MeOOC COOMe hq )TMCO〇Me 15

1) KOH 2) AcOH 〇 -〇Me 7.1 IV.5 OMe IV.4 'OMe IV.4' 經濟部智慧財產局員工消費合作社印製 (IV.2)之合 &lt; 將2,3-0-亞異丙基-丙二羥醛(Iv.l,⑹4莫耳,1〇75公斤2〇 % w/w (IV.l)在四氫咬喃中之溶液)與丙二酸二甲自^當量 ,I654莫耳’训公斤)混合,並於2〇〇c下攪摔3小時。添 加吡啶(0.5當量,827莫耳,65.5公斤),並將反應混合物 加熱至45 c。在此溫度下,添加醋酸酐(3當量,4%2莫耳 ,506公斤)在四氫呋喃(5〇6公斤)中之溶液,歷經4小時期 -49 間。在45C下加熱12小時後,#真空蒸發移除大部份溶劑 (12⑻公斤),並將殘留油以甲苯(25〇〇公斤)稀釋。於2小時 期間内,將有機溶液添加至激烈搜拌之含水碳酸氮納懸浮 液中,其係預先經由將固體碳酸氣納(19〇公斤)與⑴碳酸 5氫鈉(1760公斤)混合而製成。相分離後,移除水相,並將 有機相以1N碳酸氫納(176〇公斤)洗務。然後,在減壓下蒸 發大部份曱笨至殘留量為約“ο公斤。進一步移除曱苯 及溶劑轉換成甲醇,係經由與甲醇共沸蒸餾進行,其方式 是重複(兩次)添加曱醇(500公斤),並在減壓下蒸發相同 10量(500公斤)。最後,添加甲醇(83〇公斤),產生中間物 IV.2 (1280公斤,在曱醇中之23 6%溶液)。將中間物ϊν.2以 本身使用在下一步驟中。 (ΐν·4/ΐν·4,)自(IV.2)之合成·· 經濟部智慧財產局員工消费合作社印製 將中間物(IV.2) (5〇3莫耳,wo公斤,23 w/w之IV2在 15曱醇中)與硝基曱炫&gt;(1.1當量,553莫耳,62公斤,55%w/w 硝基甲炫在曱醇中)混合,並於此經攪拌之反應混合物中 ,於冷卻下,添加1,8-二氮雙環并[5.4_〇]十一 _7·烯(ο」當量 ,5〇,3莫耳,7.6公斤),歷經3〇分鐘期間,保持内部溫度&lt;25 °C。在室溫下持續攪拌3小時。使反應混合物冷卻至〇«&gt;〇, 2〇 並於分鐘内逐滴添加甲醇中之2N甲醇鈉(1.1當I,553 莫耳’ 100公斤,甲醇鈉在曱醇中之3〇% w/w溶液),保持 内部溫度在0°C下。在〇。(:下30分鐘後,將反應混合物於1 小時期間’分配至濃硫酸(2·5當量,12兇莫耳,128公斤, 96%硫酸)在曱醇(2〇〇公斤)中之經冷卻(〇。〇激烈攪拌溶液 -50- 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) B7 發明說明(49) 内’保持内部溫度&lt;10。〇。將反應混合物進一步冷卻至0〇C ’並添加至醋酸乙酯(450公斤)與IN碳酸氫鈉(1.9當量, 1905公斤)之經激烈攪拌冷卻(0。〇之兩相系統中,歷經1 小時期間’保持内部溫度&lt;15°C。將反應混合物過濾,以 移除大部份已沉澱之硫酸鈉。相分離後,收集有機相,並 將水相以醋酸乙酯萃取四次(醋酸乙酯之總量:2乃0公斤) 。將已收集之有機相以鹽水(300公斤23%w/w氯化鈉溶·液) 洗條’及在減壓下蒸發至殘留量為75〇公斤(含有約66公斤 中間物IV.4)。將中間物Ιν·4以本身使用在下一步驟中。 之合味 於(IV.4) (750公斤溶液,約66公斤IV.4,在甲醇中)之經 搜摔溶液中,添加水(Μ公斤)與氫氧化鉀(Μ3莫耳,卵公 斤’幻%氫氧化鉀水溶液),並將反應混合物加熱至回流 ’歷經2小時。快速冷卻至35。(:後,添加醋酸(83〇莫耳,46 公斤96%醋酸),並使反應混合物在減壓下蒸發,歷經1〇 小時期間,至殘留量為約2〇〇公斤。於冷卻至室溫後,添 加更多醋酸(354公斤),歷經丨小時期間。在室溫下攪拌2 小時後,藉真空蒸發移除大部份醋酸,歷經1〇小時期間 ,至殘留量為约25〇公斤。添加水(8〇〇公斤),並將水溶液 以醋酸乙醋萃取王次以·公斤)。將合併之有機層以m 碳酸氫鈉洗滌兩次(2X586公斤)。以…碳酸氫鈉之第三次 洗滌,係以pH控制進行;添加出碳酸氫鈉,直到ρΗ值為 6.8-7.2(使用約410公斤…碳酸氫鋼)。從醋酸乙醋至異丙 醇之溶劑襲’係㈣錢在下級㈣溶液至殘留 •51 - 1323260 A7 B7 五、發明說明(50) 量為200公斤,添加異丙醇(350公斤),在減壓下蒸發有機 溶液至殘留量為200公斤,及添加異丙醇(350公斤),以進 行之。將反應混合物加熱至60-70°C,並在該溫度及減壓下 ,進一步蒸發異丙醇至殘留量為約144公斤。在過濾後, 5 使反應混合物冷卻至0°C,歷經4-5小時期間,允許中間物 (IV.5)進行結晶化作用。結晶之過濾及乾燥(在40°C下真空 乾燥)產生中間物(IV.5)(27公斤)。將中間物IV.5以本身使 用在下一步驟中。 (7.1)之合成: 經濟部智慧財產局員工消費合作社印製 10 於中間物(IV.5)(180莫耳,30公斤)在四氫呋喃(160公斤) 中之溶液内,在30分鐘内添加硼氫化鋰(1.1當量,198莫 耳,43.1公斤,10%硼氫化鋰在四氫呋喃冲之溶液)。將反 應混合物加熱至50°C,歷經1小時期間,並於該溫度下攪 拌2小時。使所獲得之懸浮液冷卻至-10°C,並分配鹽酸(1.2 15 當量,相對於LiBH4,238莫耳,27.2公斤32%鹽酸),歷經 4小時期間,保持内部溫度&lt;-5°C。於-l〇°C下再攪拌2小時 後,添加三乙胺(1.1當量,相對於HC1,261莫耳,26.5公 斤),歷經1小時期間,同時保持内部S度&lt;〇°C。溶劑轉換 成醋酸乙酯,係經由在大氣壓下蒸餾溶劑至殘留量約100 20 公斤,添加醋酸乙酯(360公斤),及進一步蒸餾呋喃 /醋酸乙酯溶劑混合物,且持續添加醋酸乙酯,以保持恒 定體積,以進行之。持續此程序,直到四氫呋喃/醋酸乙 酯比例為4 : 1(藉氣相層析法確認)。使所形成之混合物 冷卻至0°C,過濾,並將濾餅以兩份醋酸乙酯洗滌(2x30公 -52- 本纸張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A7 B7 五、發明說明(51) 斤)。使所收集之濾液蒸發,產生化合物(7.1)(18公斤)。 化合物7.1之身分,係使用HPLC、NMR及對掌性氣相層析 法,利用得自實例III之參考試樣確認。1) KOH 2) AcOH 〇-〇Me 7.1 IV.5 OMe IV.4 'OMe IV.4' Printed by the Intellectual Property Office of the Ministry of Economic Affairs, Employees' Consumption Cooperative (IV.2) &lt; 2,3-0- Isopropyl-propanedialdehyde (Iv.l, (6) 4 mole, 1〇75 kg 2〇% w/w (IV.l) solution in tetrahydroanion) and malonate dimethyl from ^ Equivalent, I654 Moer's training kg) mixed, and stirred for 2 hours under 2〇〇c. Pyridine (0.5 eq, 827 mol, 65.5 kg) was added and the reaction mixture was heated to 45 c. At this temperature, a solution of acetic anhydride (3 equivalents, 4% 2 moles, 506 kg) in tetrahydrofuran (5 〇 6 kg) was added over a period of 4 hours - 49. After heating at 45 C for 12 hours, most of the solvent (12 (8) kg) was removed by vacuum evaporation, and the residual oil was diluted with toluene (25 〇〇 kg). The organic solution was added to the vigorously mixed aqueous sodium bicarbonate suspension over a period of 2 hours, which was previously prepared by mixing solid carbonic acid sodium (19 〇 kg) with (1) sodium hydrogencarbonate (1760 kg). to make. After phase separation, the aqueous phase was removed and the organic phase was washed with 1N sodium bicarbonate (176 g). Then, most of the evaporation was carried out under reduced pressure until the residual amount was about "o kg. Further removal of toluene and conversion of the solvent to methanol was carried out by azeotropic distillation with methanol by repeating (twice) addition. Sterol (500 kg) and evaporate the same 10 (500 kg) under reduced pressure. Finally, add methanol (83 〇 kg) to give intermediate IV.2 (1280 kg, 23 6% solution in decyl alcohol) The intermediate ϊν.2 is used in the next step itself. (ΐν·4/ΐν·4,) from the synthesis of (IV.2) · The Ministry of Economic Affairs, the Intellectual Property Office, the employee consumption cooperative, prints the intermediate ( IV.2) (5〇3 mol, wo kg, 23 w/w IV2 in 15 sterol) and nitro hydrazine &gt; (1.1 equivalent, 553 m, 62 kg, 55% w/w Mixing with thiol in decyl alcohol, and adding 1,8-diazabicyclo[5.4_〇] eleven-7 olefin (ο" equivalent, 5 under stirring in the reaction mixture. 〇, 3 m, 7.6 kg), keep the internal temperature &lt;25 °C during 3 〇 minutes. Stirring was continued for 3 hours at room temperature. The reaction mixture was cooled to 〇«&gt; 〇, 2 〇 and 2N sodium methoxide in methanol (1.1 when I, 553 Mo' 100 kg, sodium methoxide in decyl alcohol 3 〇 % w/ was added dropwise in minutes. w solution), keeping the internal temperature at 0 °C. Here. (: After the next 30 minutes, the reaction mixture was distributed to concentrated sulfuric acid (2.5 eq, 12 murole, 128 kg, 96% sulphuric acid) in decyl alcohol (2 〇〇 kg) during 1 hour. (〇.〇 Intense Stirring Solution - 50 - This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm) B7 Description of invention (49) Inside 'Keep internal temperature&lt;10. 〇. Further cool the reaction mixture To 0〇C' and added to ethyl acetate (450 kg) and IN sodium bicarbonate (1.9 equivalents, 1905 kg) with vigorous stirring and cooling (0. in a two-phase system, maintaining internal temperature over a period of 1 hour) &lt; 15 ° C. The reaction mixture was filtered to remove most of the precipitated sodium sulfate. After phase separation, the organic phase was collected, and the aqueous phase was extracted four times with ethyl acetate (ethyl acetate: 2 is 0 kg). The collected organic phase is washed with brine (300 kg 23% w/w sodium chloride solution) and evaporated under reduced pressure to a residual amount of 75 kg (containing about 66 kg) Intermediate IV.4). The intermediate Ιν·4 was used as it is in the next step. The taste is in (IV.4) (750 kg solution, about 66 kg IV.4 in methanol) in the drop solution, add water (Μ kg) and potassium hydroxide (Μ 3 mol, egg kg 'magnesium potassium hydroxide aqueous solution), and The reaction mixture was heated to reflux for 2 hours. Quickly cooled to 35. (:, then, acetic acid (.sup.ss.sssssssssssssssssssssssssssssssssssssssssssssssssssssss , to a residual amount of about 2 〇〇 kg. After cooling to room temperature, add more acetic acid (354 kg), during the 丨 hour period. After stirring at room temperature for 2 hours, remove most of the acetic acid by vacuum evaporation. After a period of 1 hour, the residual amount is about 25 〇 kg. Add water (8 〇〇 kg), and extract the aqueous solution with ethyl acetate to the king of kilograms. The combined organic layer is m sodium bicarbonate. Wash twice (2X 586 kg). The third wash with sodium bicarbonate is carried out with pH control; sodium bicarbonate is added until the pH value is 6.8-7.2 (using about 410 kg...carbonic acid steel). Ethyl acetate to isopropanol solvent attack 'system (four) money in the lower (four) solution Residues • 51 - 1323260 A7 B7 V. Description of the invention (50) The amount is 200 kg, add isopropanol (350 kg), evaporate the organic solution under reduced pressure to a residual amount of 200 kg, and add isopropanol (350 kg) The reaction mixture was heated to 60-70 ° C, and isopropanol was further evaporated to a residual amount of about 144 kg at this temperature and reduced pressure. After filtration, 5 the reaction mixture was cooled to 0. At ° C, the intermediate (IV.5) was allowed to undergo crystallization over a period of 4-5 hours. Filtration of the crystals and drying (vacuum drying at 40 ° C) gave intermediate (IV.5) (27 kg). Intermediate IV.5 was used as such in the next step. (7.1) Synthesis: Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff and Consumers Co., Ltd. 10 Add boron to the intermediate (IV.5) (180 m, 30 kg) in tetrahydrofuran (160 kg) in 30 minutes. Lithium hydride (1.1 equivalents, 198 moles, 43.1 kilograms, 10% lithium borohydride in tetrahydrofuran). The reaction mixture was heated to 50 ° C over a period of 1 hour and stirred at this temperature for 2 hours. The obtained suspension was cooled to -10 ° C, and hydrochloric acid (1.2 15 equivalents, relative to LiBH 4 , 238 mol, 27.2 kg of 32% hydrochloric acid) was dispensed, and the internal temperature was maintained for -4 ° C over a period of 4 hours. . After stirring for an additional 2 hours at -1 °C, triethylamine (1.1 equivalents, 261 moles, 26.5 kg vs. HC1) was added over the period of 1 hour while maintaining the internal S degree &lt; 〇 °C. The solvent is converted to ethyl acetate by distilling the solvent under atmospheric pressure to a residual amount of about 100 20 kg, adding ethyl acetate (360 kg), and further distilling the furan/ethyl acetate solvent mixture, and continuously adding ethyl acetate to Keep a constant volume to carry it out. This procedure was continued until the ratio of tetrahydrofuran/ethyl acetate was 4:1 (confirmed by gas chromatography). The resulting mixture was cooled to 0 ° C, filtered, and the filter cake was washed with two portions of ethyl acetate (2 x 30 - 52 - paper scale applied to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1323260 A7 B7 V. Description of invention (51) kg). The collected filtrate was evaporated to give the compound (7.1) (18 kg). The identity of Compound 7.1 was confirmed by HPLC, NMR and palm gas chromatography using a reference sample obtained from Example III.

-裝— 訂. .線·-Installation - Order. .

經濟部智慧財產局員工消費合作社印製 3 5 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐)Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives Printed 3 5 This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm)

Claims (1)

1323260 Ψ 公告本.丨 Α8 Β8 C8 D8 專利申請案第91120509號 ROC Patent Appln. No. 91120509 修正後無中請專利碎圍中文本-附件(三) AmpndpH ΐη (Ήίηρςρ - F.nr.l ΠϊΤ、 六、申請專利範圍 (民國98年10月28曰送呈) (Submitted on October 28, ί 5 1. 一種合成式(7)六氫-咲喃并[2,3-b]呋喃-3-醇之方法“·----------- 其係從式(1)中間物開始,其中P1與P2各獨立表示氫 ,羥基保護基,或可一起形成二-Cw烷基亞甲基, OP2 pl〇^YH 使該式(1)中間物轉變成式(3)硝基曱烷衍生物,其中_ R1表示Cm烷基,R2表示氫或C(=0)0R3,R3表示CN 6烧基, OP2 R2 P1〇v^J\^A.c〇〇R1 3、N〇2 10 接著使該硝基曱烷衍生物轉變成式(6)四氫呋喃衍生 物,其中OR4表示O-Cu烷基, HO1323260 公告 Announcement. 丨Α8 Β8 C8 D8 Patent Application No. 91120509 ROC Patent Appln. No. 91120509 After the amendment, please patent the broken text-Annex (3) AmpndpH ΐη (Ήίηρςρ - F.nr.l ΠϊΤ, 6. The scope of application for patents (submitted on October 28, 1998) Submitted on October 28, ί 5 1. A synthetic (7) hexahydro-puro[2,3-b]furan-3-ol The method "·----------- begins with the intermediate of formula (1), wherein P1 and P2 each independently represent hydrogen, a hydroxy protecting group, or may together form a di-Cw alkylmethylene group , OP2 pl〇^YH converts the intermediate of the formula (1) into a nitrosterane derivative of the formula (3), wherein _R1 represents a Cm alkyl group, R2 represents hydrogen or C(=0)0R3, and R3 represents CN6. Burning group, OP2 R2 P1〇v^J\^Ac〇〇R1 3, N〇2 10 Next, the nitrodecane derivative is converted into a tetrahydrofuran derivative of the formula (6), wherein OR4 represents an O-Cu alkyl group, HO OH OR* 15 經濟部智慧財產局員工消費合作社印製 然後,在強酸存在下及在低於15°c溫度下,藉由分子 内環化反應,使式(6)中間物轉變成式(7)六氫-呋喃并 [2,3-b]呋喃-3-醇。 HO ip 20 2.根據申請專利範圍第1項之方法,其中係利用Nef反 -54 - 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 91409B-追 3 1323260 A8 B8 C8 D8 六、申請專利範圍 應,使式(3)中間物轉變成式(6)中間物。 3.根據申請專利範圍第1項之方法,其包括以下步驟: a)利用 Witting 反應、Horner-Emmons 反應、 Knoevenagel反應或Reformatsky反應,使式(1)中間 5 物縮合 OP2 P1〇々 造成式(2) α,/3-不飽和酯, ΟΡ2 ψ 10 b)在鹼存在下及在反應溫度設定於約0°c至約100°c ,使該式(2)酯與硝基甲烷反應,造成式(3)中間物, )PZ R2 Pi〇.OH OR* 15 Printed by the Intellectual Property Office of the Ministry of Economic Affairs, and then converted into the formula (6) by intramolecular cyclization in the presence of a strong acid and at a temperature below 15 °C. Hexahydro-furo[2,3-b]furan-3-ol. HO ip 20 2. According to the method of claim 1 of the scope of patent application, which uses Nef anti-54 - this paper scale applies Chinese National Standard (CNS) A4 specification (210x297 mm) 91409B-chasing 3 1323260 A8 B8 C8 D8 six The scope of the patent application should be such that the intermediate of formula (3) is converted into the intermediate of formula (6). 3. The method according to claim 1, wherein the method comprises the steps of: a) using a Witting reaction, a Horner-Emmons reaction, a Knoevenagel reaction or a Reformatsky reaction to condense the intermediate 5 of the formula (1) with an OP2 P1 〇々 form ( 2) α, /3-unsaturated ester, ΟΡ2 ψ 10 b) reacting the ester of formula (2) with nitromethane in the presence of a base and at a reaction temperature of from about 0 ° C to about 100 ° C. Formula (3) Intermediate, ) PZ R2 Pi〇. 經濟部智慧財產局員工消費合作社印制衣 15 C)在溫度設定介於約-78°c至約55°c之間,使該式(3) 中間物接受Nef反應,導致式(4)與(4’)中間物,Ministry of Economic Affairs, Intellectual Property Bureau, Staff Cooperatives, Printing and Clothing Co., Ltd. 15 C) The temperature is set between about -78 ° C and about 55 ° C, so that the intermediate of the formula (3) accepts the Nef reaction, resulting in the formula (4) and (4') intermediate, HO R2HO R2 COOR1 4· OR4 d)使該式(4)與(4’)中間物轉變成式(6)中間物,及 -55 - 本纸張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1323260 A8 B8 C8 D8 申請專利範圍 HOCOOR1 4· OR4 d) converts the intermediates of formula (4) and (4') into intermediates of formula (6), and -55 - this paper scale applies to China National Standard (CNS) A4 specification (210 X 297 PCT) 1323260 A8 B8 C8 D8 Patent application scope HO 6〇R4 OH e)在強酸存在下及在低於15°C溫度下,藉由分子内 環化反應,使式(6)中間物轉化成式(7)化合物。 4.根據申請專利範圍第1、2或3項之之方法,其包括以 下步驟: a)使式(1)中間物與CHR2縮合,其中 R5表示氫、羧酸酯、鱗鹽或膦酸酯, 10 ρι〇.6〇R4 OH e) The intermediate of formula (6) is converted to the compound of formula (7) by intramolecular cyclization in the presence of a strong acid and at a temperature below 15 °C. 4. The method according to claim 1, 2 or 3, which comprises the steps of: a) condensing an intermediate of formula (1) with CHR2, wherein R5 represents hydrogen, a carboxylic acid ester, a scale salt or a phosphonate. , 10 ρι〇. ΗΗ ORt 經濟部智慧財產局員工消費合作社印製ORt Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 15 造成式(2) α,/5 -不飽和酯 0Ρ2 R2 P1Q b)使該式(2)酯與硝基甲烷反應,造成式(3)中間物 0P2 COOR1 C)使該式(3)中間物接受Nef反應,其方式是將其以 鹼,及接著以強酸處理,而造成式(4)與(4’)中間 物之混合物, -56 - 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A8 B8 C8 D8 六、申請專利範圍15 (2) α,/5 -unsaturated ester 0Ρ2 R2 P1Q b) reacting the ester of formula (2) with nitromethane, resulting in the intermediate of formula (3) 0P2 COOR1 C) intermediate the formula (3) The Nf reaction is carried out by treating it with a base and then with a strong acid to form a mixture of intermediates of formula (4) and (4'), -56 - the paper scale applies to the Chinese National Standard (CNS) A4 Specifications (210x297 mm) 1323260 A8 B8 C8 D8 VI. Patent application scope 4 OR44 OR4 COOR1 4&lt; OR4 d)惟若R2不為氫,則使式(4)與(4J中間物脫羧基化 ,因此個別形成式(5)與(5’)中間物,COOR1 4&lt; OR4 d) However, if R2 is not hydrogen, the intermediates of formula (4) and (4J are decarboxylated, so that intermediates of formula (5) and (5') are formed individually. 5' e)以適當還原劑,使式(4)與(4’)中間物,或式(5)與 (5’)中間物還原,而造成式(6)中間物,及5' e) reducing the intermediate of formula (4) and (4'), or the intermediate of formula (5) and (5') with a suitable reducing agent to form an intermediate of formula (6), and 6 OR4 經濟部智慧財產局員工消費合作社印製 15 10 f)藉由分子内環化反應,使式(6)中間物轉化成式(7) 化合物。 5.根據申請專利範圍第1、2或3項之方法,其中式(3)中 間物係藉由包括以下步驟之方法製成,首先使式(1) 中間物與硝基甲烷縮合,而造成式(8)中間物,其次 ,使該式(8)中間物與CHI^RS-CtCO-OR1反應,其 中R8為氫或二羧酸。 -57 - 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 申請專利範6 OR4 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed 15 10 f) The intermediate of formula (6) is converted to the compound of formula (7) by intramolecular cyclization. 5. The method of claim 1, wherein the intermediate of formula (3) is prepared by a process comprising the steps of: first condensing the intermediate of formula (1) with nitromethane, resulting in The intermediate of formula (8), and secondly, the intermediate of formula (8) is reacted with CHI^RS-CtCO-OR1, wherein R8 is hydrogen or a dicarboxylic acid. -57 - This paper size applies to China National Standard (CNS) A4 specification (210x297 mm) 6·根據申請專利範圍第i、2或3項之方法,其中式⑹ 中間物係藉由包括以下步驟之方法製成,首先以適當 還原劑,使式(3)其中R2為氫之中間物還原,造成式 (9)中間物,其次,使所獲得之式中間物接受Nef 反應,以驗,然後以強酸處理。6. The method of claim i, 2 or 3, wherein the intermediate of formula (6) is prepared by a process comprising the steps of: first, using an appropriate reducing agent, wherein R2 is an intermediate of hydrogen Reduction, resulting in an intermediate of formula (9), and secondly, the resulting intermediate is subjected to a Nef reaction for examination and then treatment with a strong acid. C -OH 10 經濟部智慧財產局員工消費合作社印製 15 20 7. 根據申請專利範圍第i、2或3項之方法,其中尺丨與 R各獨立為Cl-6院基,且R4為烧基。 8. 根據申請專利範圍第i、2或3項之方法,其中Rl、 R3及R4各獨立為甲基、乙基、丙基、異丙基'正-丁 基、異丁基、第二-丁基、第三_ 丁基或戊基。 9. 根據申請專利範圍第i ' 2或3項之方法,其中一與 p2—起形成酸不安定性二_Cl6烷基亞甲基。 10. 根據申請專利範圍第i、2或3項之方法,其中pi與 p2 —起形成二-(C1-6)烷基亞甲基。 U·根據申請專利範圍第4項之方法,其中r5為氫、r1〇_ C(=〇)-、(R6)3P=,其中“為^^烷基、c6_12芳基 或芳基-C1-6烷基,或(R70)2P(=0),其中r7為Cl6 貌基、C6-12芳基、C6-12芳基-C1-6烷基。 12·根據申請專利範圍第1、2或3項之方法,其中尺8為 58 本紙張尺度適財關家標準(CNS)A4規格(2】G χ撕公爱) /、、申請專利範 圍 氫或 13. 一種具有式(3)之令間物, 'COOR' N〇2 3 5 10 其中P1與p2各獨立表示氫,羥基保護基, 形成二-c,_6絲亞甲基,Ri表示Ci6貌基,—起 或C(=〇)〇r3,R3表示c丨·6院基, 表不氫 其條件是當R2為氫,且pi與p2 一起换 , 丙基時,則R1不為甲基或乙基。 形成亞異 14· 一種具有式(4)或(4,)之中間物, 'R2 HO R2 4* 〇R&lt; COOR1 經濟部智慧財產局員工消費合作杜印製 15 其中R1表示Cw院基;R2表示氫或c(=〇)〇r3 示Ci_6院基;OR1表示〇_(^·6院基。 —種具有式(5)或(5’)之中間物,C - OH 10 Ministry of Economic Affairs Intellectual Property Office Employees' Consumption Cooperatives Printed 15 20 7. According to the method of the application of the scope of the patents, item i, 2 or 3, where the ruler and R are independent of the Cl-6 yard, and R4 is burnt base. 8. The method of claim i, 2 or 3, wherein each of R1, R3 and R4 is independently methyl, ethyl, propyl, isopropyl 'n-butyl, isobutyl, second- Butyl, tert-butyl or pentyl. 9. According to the method of claim i or 2 or 3, one of them forms an acid-labile di-Cl6 alkylmethylene group with p2. 10. The method of claim i, 2 or 3, wherein pi and p2 together form a bis-(C1-6)alkylmethylene group. U. According to the method of claim 4, wherein r5 is hydrogen, r1〇_C(=〇)-, (R6)3P=, wherein "is ^^ alkyl, c6_12 aryl or aryl-C1- 6 alkyl, or (R70) 2P (=0), wherein r7 is a Cl6 top group, a C6-12 aryl group, a C6-12 aryl-C1-6 alkyl group. 12. According to the scope of the patent application No. 1, 2 or The method of 3 items, wherein the ruler 8 is 58 paper size standards (CNS) A4 specifications (2) G χ tear public love) /, the patent application scope hydrogen or 13. A method with the formula (3) Interstitial, 'COOR' N〇2 3 5 10 wherein P1 and p2 each independently represent hydrogen, a hydroxy protecting group, form a di-c, _6 silk methylene group, and Ri represents a Ci6 surface group, or a C (= 〇) 〇r3, R3 represents c丨·6, and the condition is that when R2 is hydrogen and pi is replaced with p2, when propyl is used, then R1 is not methyl or ethyl. Intermediate with formula (4) or (4,), 'R2 HO R2 4* 〇R&lt; COOR1 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperation du printing 15 where R1 denotes Cw yard base; R2 denotes hydrogen or c(= 〇)〇r3 shows the Ci_6 yard base; OR1 means 〇_(^·6 yard base. Formula (5) or (5 ') of the intermediate, 其中OR1表示〇-CU6烷基。 -59 - ;R3表 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1 OR1 丄wou A8 B8 C8Wherein OR1 represents a 〇-CU6 alkyl group. -59 - ;R3 table This paper size applies to China National Standard (CNS) A4 specification (210x297 mm) 1 OR1 丄wou A8 B8 C8 16·根據中請專利範圍第1項之方法,其係從式⑽中間 物開始其中pi與p2 一起採用而形成亞異丙基, 使該式(1.1)中間物縮合,造成式(21)中間物,其中 P1與P2 —起採用而形成亞異丙基,r2表示_ C(=0)0R3,其中R3為甲基,且Ri為曱基, 1016. The method of claim 1, wherein starting from the intermediate of formula (10), wherein pi is used together with p2 to form an isopropylidene group, the intermediate of formula (1.1) is condensed, resulting in the middle of formula (21) Wherein P1 and P2 are used together to form an isopropylidene group, and r2 represents _C(=0)0R3, wherein R3 is a methyl group and Ri is a fluorenyl group, 10 P〇〇Me COOMe 2.1P〇〇Me COOMe 2.1 COOMe COOMe 15 經濟部智慧財產局員工消費合作社印製 使該式(2.1)酯反應至式(3.1)硝基甲烷衍生物中,其 中P1與P2 一起採用而形成亞異丙基,R2表示_ C(=0)0R3,其中R3為甲基,且R1為甲基, 3.1 使用鹼,及接著為酸,使該式(3.1)中間物轉變,產生 式(4.1)與(4’.1)中間物,其中r2表示_c(=〇)〇r3,其 中R3為甲基,r1為甲基,及R4為曱基, 20COOMe COOMe 15 Printed by the Intellectual Property Office of the Intellectual Property Office of the Ministry of Economic Affairs, the (2.1) ester is reacted into the nitromethane derivative of formula (3.1), wherein P1 is used together with P2 to form an isopropylidene group, and R2 represents _C. (=0)0R3, wherein R3 is methyl and R1 is methyl, 3.1 using a base, and then an acid, the intermediate of formula (3.1) is converted to produce intermediates of formula (4.1) and (4'.1) And r2 represents _c(=〇)〇r3, wherein R3 is methyl, r1 is methyl, and R4 is fluorenyl, 20 COOMe -60 - 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐) 1323260 A8 B8 C8 D8 六、申請專利範圍 使式(4.1)中間物脫羧基化,導致式(5.1)中間物 中R4為甲基, 其 5.1COOMe -60 - This paper size applies to China National Standard (CNS) A4 specification (210x297 mm) 1323260 A8 B8 C8 D8 VI. The scope of patent application decarboxylates the intermediate of formula (4.1), resulting in the intermediate of formula (5.1) R4 is methyl, its 5.1 ΟΜβ Ό 經濟部智慧財產局員工消費合作社印製 以適當還原劑,使該式(5.1)中間物還原,造成式(6.1) 中間物,其中R4為甲基, 6.1 10 藉由分子内環化反應,使式(6.1)中間物轉變成化合物 7.1。 ΗΟΟΜβ Ό Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative, printed with appropriate reducing agents to reduce the intermediate of formula (5.1), resulting in the intermediate of formula (6.1), where R4 is methyl, 6.1 10 by intramolecular cyclization The intermediate of formula (6.1) is converted to compound 7.1. ΗΟ Ό 7.1 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公釐)7.1 7.1 This paper scale applies to China National Standard (CNS) A4 specification (210x297 mm)
TW91120509A 2002-09-09 2002-09-09 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol TWI323260B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW91120509A TWI323260B (en) 2002-09-09 2002-09-09 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW91120509A TWI323260B (en) 2002-09-09 2002-09-09 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol

Publications (1)

Publication Number Publication Date
TWI323260B true TWI323260B (en) 2010-04-11

Family

ID=45074035

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91120509A TWI323260B (en) 2002-09-09 2002-09-09 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol

Country Status (1)

Country Link
TW (1) TWI323260B (en)

Similar Documents

Publication Publication Date Title
CN100519561C (en) Process for preparing hexahydro-furo [2, 3-b ] furan-3-ol
US10717743B2 (en) Intermediates and methods for the synthesis of halichondrin B analogs
Hernandez et al. Synthesis of (+)-and (-)-N-BOC-7-Azabicyclo [2.2. 1] heptan-2-ones, Versatile Intermediates for the Enantiospecific Synthesis of (+)-and (-)-Epibatidine and Analogs
JP2018523633A (en) Method for producing brivaracetam
AU2002333809A1 (en) Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol
JP2020534336A (en) Polycyclic compounds as IDO inhibitors and / or IDO-HDAC double inhibitors
WO2012092168A1 (en) Fused 6,5 bicyclic ring system p2 ligands, and methods for treating hiv
TWI323260B (en) Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol
JP2014125462A (en) Epoxide derivative and production method thereof
EP2643326B1 (en) Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol
JP7609438B2 (en) Method for producing a cyclopentane compound, a method for producing a lactone compound, a method for producing a diol compound, and a compound
US8802724B2 (en) Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
JP2014125463A (en) Alcohol derivative and production method thereof
JPS60197662A (en) Carbamate and its preparation
JP2002069074A (en) Method for producing optically active endo-7-oxabicyclo [2.2.1] hept-5-en-2-carboxylic acid
HK1160445A (en) Method for synthesis of (1s, 2r)-milnacipran

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent